- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 13.11.2023
- Impfdatum
- 07.01.2022
- Beginn
- 31.08.2023
- Tage bis Beginn
- 601,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acinetobacter test positive
Acute respiratory failure
Akinesia
Angiogram pulmonary abnormal
Bladder mass
Blood culture negative
Blood lactic acid normal
Brain natriuretic peptide increased
Bronchial secretion retention
COVID-19
COVID-19 pneumonia
Cellulitis
Device intolerance
Echocardiogram abnormal
Dyspnoea
Dyspnoea exertional
Hypertransaminasaemia
Hypoxia
Symptomtext
BRIEF OVERVIEW: Admission Date: 8/31/2023 Discharge Date: Sep 21, 2023 Discharge Disposition: skilled nursing facility DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] HOSPITAL COURSE: Patient is a 68 y.o. female with a past medical history including COPD without baseline O2 need, IgG lambda multiple myeloma currently undergoing treatment, coronary artery disease, achalasia s/p botox, essential hypertension, anxiety, and depression who was admitted 8/31/2023 for acute on chronic hypoxic,hypercapnic respiratory failure secondary to Covid-19 pneumonia. Patient presented to ED after she was noted to be diaphoretic and hypoxic during an outpatient infusion appointment. On arrival she required 4L NC supplemental oxygen. Work up was notable for Covid-19 + PCR and uptrending troponin. CTA thorax demonstrated bilateral pneumonia with underlying severe emphysema. She as transferred to another hospital for cardiology consult and further care. During admission, patient intermittently required HFNC for respiratory support. Bipap was attempted for increased respiratory acidosis, but she did not tolerate this. She received Remdesivir and IV solumedrol. Sputum culture was positive for Acinetobacter pittii, which was concerning for an aspiration pneumonia based on the patient's chronic dysphagia, so she also received a 7 day course on Unasyn. Pulmonology was consulted and assisted with her management. Her respiratory status slowly improved to needing 2L NC at rest and 3L with ambulation. Expect a prolonged recovery due to the severity of her underlying emphysema. Cardiology was consulted due to the elevated troponins on admission. Echocardiogram demonstrated LVEF 33% with akinesis of the basal inferior wall and mild dilation of the left ventricle. She was started on Coreg and Losartan for medical management. Cardiology recommended further outpatient work-up with cardiac MRI/ repeat echo. SLP was consulted during the admission, as well. They completed an FEES that demonstrated mild risk for aspiration and suggested continued regular diet with thin liquids to supplement PEG tube feeds. She developed leukopenia. B12 levels were checked and WNL. Revlimid held for neutropenia discussed with oncologist to resume 9/26. PT and OT were consulted and recommended SAR on discharge and SAR requested 20 day respiratory isolation with severity of illness. Daughter at bedside for transportation and all questions answered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 21,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 12/19/2022 (3 hours) Hospital Emergency DIAGNOSIS at time of disposition: 1. Abdominal wall cellulitis 2. Bladder mass
- Vorgeschichte
- Anxiety and depression COPD (chronic obstructive pulmonary disease) (HCC) HTN (hypertension) Acquired hypothyroidism Dysphagia Multiple myeloma (HCC) Coronary artery disease involving native coronary artery of native heart without angina pectoris Generalized anxiety disorder Lung nodule 4 x 8 mm right upper lobe identified 5/19/20 waxing and waning nodules Former smoker quit 10/2021 Nocturnal hypoxia Brain lesion COVID-19 Leukocytosis, unspecified type Acute respiratory failure with hypoxia (HCC) Lung nodules Encounter for antineoplastic chemotherapy Therapeutic drug monitoring Bone lesion Bronchiectasis without complication (HCC) Paroxysmal atrial fibrillation (HCC) RCA stent 1996 Hyponatremia Head injury Port-A-Cath in place Neuropathy New cardiomyopathy (HCC)
- Andere Medikamente
- acyclovir (ZOVIRAX) 400 mg tablet albuterol HFA (PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) buPROPion (WELLBUTRIN XL) 300 mg 24 hr tablet carvedilol (COREG) 6.25
- Allergien
- DoxycyclineHeadache
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 13.11.2023
- Impfdatum
- 07.01.2022
- Beginn
- 31.08.2023
- Tage bis Beginn
- 601,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acinetobacter test positive
Acute respiratory failure
Akinesia
Angiogram pulmonary abnormal
Bladder mass
Blood culture negative
Blood lactic acid normal
Brain natriuretic peptide increased
Bronchial secretion retention
COVID-19
COVID-19 pneumonia
Cellulitis
Device intolerance
Echocardiogram abnormal
Dyspnoea
Dyspnoea exertional
Hypertransaminasaemia
Hypoxia
Symptomtext
BRIEF OVERVIEW: Admission Date: 8/31/2023 Discharge Date: Sep 21, 2023 Discharge Disposition: skilled nursing facility DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] HOSPITAL COURSE: Patient is a 68 y.o. female with a past medical history including COPD without baseline O2 need, IgG lambda multiple myeloma currently undergoing treatment, coronary artery disease, achalasia s/p botox, essential hypertension, anxiety, and depression who was admitted 8/31/2023 for acute on chronic hypoxic,hypercapnic respiratory failure secondary to Covid-19 pneumonia. Patient presented to ED after she was noted to be diaphoretic and hypoxic during an outpatient infusion appointment. On arrival she required 4L NC supplemental oxygen. Work up was notable for Covid-19 + PCR and uptrending troponin. CTA thorax demonstrated bilateral pneumonia with underlying severe emphysema. She as transferred to another hospital for cardiology consult and further care. During admission, patient intermittently required HFNC for respiratory support. Bipap was attempted for increased respiratory acidosis, but she did not tolerate this. She received Remdesivir and IV solumedrol. Sputum culture was positive for Acinetobacter pittii, which was concerning for an aspiration pneumonia based on the patient's chronic dysphagia, so she also received a 7 day course on Unasyn. Pulmonology was consulted and assisted with her management. Her respiratory status slowly improved to needing 2L NC at rest and 3L with ambulation. Expect a prolonged recovery due to the severity of her underlying emphysema. Cardiology was consulted due to the elevated troponins on admission. Echocardiogram demonstrated LVEF 33% with akinesis of the basal inferior wall and mild dilation of the left ventricle. She was started on Coreg and Losartan for medical management. Cardiology recommended further outpatient work-up with cardiac MRI/ repeat echo. SLP was consulted during the admission, as well. They completed an FEES that demonstrated mild risk for aspiration and suggested continued regular diet with thin liquids to supplement PEG tube feeds. She developed leukopenia. B12 levels were checked and WNL. Revlimid held for neutropenia discussed with oncologist to resume 9/26. PT and OT were consulted and recommended SAR on discharge and SAR requested 20 day respiratory isolation with severity of illness. Daughter at bedside for transportation and all questions answered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 21,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 12/19/2022 (3 hours) Hospital Emergency DIAGNOSIS at time of disposition: 1. Abdominal wall cellulitis 2. Bladder mass
- Vorgeschichte
- Anxiety and depression COPD (chronic obstructive pulmonary disease) (HCC) HTN (hypertension) Acquired hypothyroidism Dysphagia Multiple myeloma (HCC) Coronary artery disease involving native coronary artery of native heart without angina pectoris Generalized anxiety disorder Lung nodule 4 x 8 mm right upper lobe identified 5/19/20 waxing and waning nodules Former smoker quit 10/2021 Nocturnal hypoxia Brain lesion COVID-19 Leukocytosis, unspecified type Acute respiratory failure with hypoxia (HCC) Lung nodules Encounter for antineoplastic chemotherapy Therapeutic drug monitoring Bone lesion Bronchiectasis without complication (HCC) Paroxysmal atrial fibrillation (HCC) RCA stent 1996 Hyponatremia Head injury Port-A-Cath in place Neuropathy New cardiomyopathy (HCC)
- Andere Medikamente
- acyclovir (ZOVIRAX) 400 mg tablet albuterol HFA (PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) buPROPion (WELLBUTRIN XL) 300 mg 24 hr tablet carvedilol (COREG) 6.25
- Allergien
- DoxycyclineHeadache
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 01.06.2023
- Impfdatum
- 18.10.2021
- Beginn
- 03.10.2022
- Tage bis Beginn
- 350,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Hypotension
Symptomtext
HYPOTENSION ACUTE RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 03.05.2023
- Impfdatum
- 20.10.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 23,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bladder cancer
Bladder mass
Bladder transitional cell carcinoma
Chronic kidney disease
Deep vein thrombosis
Glomerular filtration rate
Metastases to lymph nodes
Neoplasm malignant
Pulmonary embolism
Troponin I increased
Symptomtext
I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 CKD STAGE 3B (GFR 30-44) I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 CKD STAGE 3B (GFR 30-44) I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 CKD STAGE 3B (GFR 30-44) I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 CANCER METASTATIC TO INTRAABDOMINAL LN I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 CANCER METASTATIC TO INTRAABDOMINAL LN I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 CANCER METASTATIC TO INTRAABDOMINAL LN I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 BLADDER MASS I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 BLADDER MASS I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 BLADDER MASS I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 ELEVATED TROPONIN I I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 ELEVATED TROPONIN I I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 ELEVATED TROPONIN I I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 TRANSITIONAL CELL CARCINOMA, POSTERIOR WALL OF BLADDER I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 TRANSITIONAL CELL CARCINOMA, POSTERIOR WALL OF BLADDER I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 TRANSITIONAL CELL CARCINOMA, POSTERIOR WALL OF BLADDER I26.99 ACUTE PULMONARY EMBOLISM 5/17/2022 BLADDER CANCER, UNSPECIFIED SITE I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 5/11/2022 BLADDER CANCER, UNSPECIFIED SITE I82.413 ACUTE DVT OF BILAT FEMORAL VEINS 5/17/2022 BLADDER CANCER, UNSPECIFIED SITE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 19.10.2021
- Beginn
- 19.11.2021
- Tage bis Beginn
- 31,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebral haemorrhage
Deep vein thrombosis
Epilepsy
Haemorrhagic stroke
Hemiparesis
Hemiplegia
Symptomtext
G40.909 EPILEPSY, UNSPECIFIED 11/2/2021 HEMIPLEGIA & HEMIPARESIS, LEFT NONDOMINANT SIDE, LATE EFFECT OF HEMORRHAGIC STROKE I82.4Z2 ACUTE DVT OF LEFT CALF, UNSPECIFIED VEIN 11/19/2021 HEMIPLEGIA & HEMIPARESIS, LEFT NONDOMINANT SIDE, LATE EFFECT OF HEMORRHAGIC STROKE G40.909 EPILEPSY, UNSPECIFIED 11/2/2021 INTRACEREBRAL HEMORRHAGE, CORTICAL HEMISPHERE I82.4Z2 ACUTE DVT OF LEFT CALF, UNSPECIFIED VEIN 11/19/2021 INTRACEREBRAL HEMORRHAGE, CORTICAL HEMISPHERE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 19.10.2021
- Beginn
- 15.10.2022
- Tage bis Beginn
- 361,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Angiogram pulmonary abnormal
Anticoagulant therapy
Aortic valve incompetence
Asymptomatic bacteriuria
Atelectasis
Atrial fibrillation
COVID-19
Cardiac failure
Computerised tomogram abnormal
Dyspnoea
Echocardiogram
Ejection fraction
Gastrostomy tube removal
Malnutrition
Meningioma
Nausea
Pain
Symptomtext
Clinical Summary Patient is a 94 y.o. female with a history of CHF, recent dx of COVID on 9/26/22 who presented to RMH 10/15/2022 with dyspnea, nausea, and acute hypoxic respiratory failure. 1. Hypoxic Respiratory failure: With recent COVID infection and sats 85% on RA consistently at SNF. CTPA negative for PE, is showing atelectasis and residual findings from recent infection. Continue aggressive IS. No fever/ sputum production to indicate PNA, but monitor. Procalcitonin 0.09. TTE unremarkable. Resolved after admission and satting >91 on RA. 2. COVID-19: Date of onset- 9/26/22 with positive test and slight fever, aches at the time which improved. Received paxlovid therapy at facility. She had completed isolation at SNF. Had 3 days remdesivir and 5 days steroids completed here. 3. Afib: Continued BB and Eliquis 4. HFpEF: Echo 10/20/22 with EF 53% with mild aortic valve regurgitation without significant change from prior studies 5. Moderate malnutrition: GI removed PEG tube on 10/18/22 after discussion with family 6. Meningioma, likely schwannoma: seen on CT imaging. Discusses with Daughter without further workup needs at this time 7. Asymptomatic bacteruria: Given Keflex for 5 days 8. Blurry Vision: intermittent, probably related to macular degeneration. Outpatient ophthalmologist to follow
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 01.10.2021
- Beginn
- 01.08.2022
- Tage bis Beginn
- 304,0
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
Blood test
Chest X-ray
Chest pain
Computerised tomogram normal
Electrocardiogram
Pulmonary embolism
SARS-CoV-2 test negative
Thrombosis
Ultrasound scan
Symptomtext
Roughly 10 months after the vaccine I started developing chest pain. I went to the ER where I was diagnosed with multiple pulmonary emboli in my lungs and a blood clot in my right arm. I was prescribed blood thinning medication and discharged same day. I have now been on blood thinning medication since 08/2022. Scheduled for a follow up in December.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- CT scan normal, Ultrasound for my right arm; Routine BW; chest x-ray; COVID 19 test negative; EKG
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Multiple Pulmonary Emboli
- Andere Medikamente
- Levothyroxine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 23.02.2021
- Beginn
- 01.03.2022
- Tage bis Beginn
- 371,0
- Dosis
- 3
- Route/Site
- SYR / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Death
Dementia
Gait disturbance
Laboratory test abnormal
Magnetic resonance imaging
Thrombosis
Wheelchair user
Symptomtext
I am writing this report for my mother who is now dead due to these shots. Prior to these shots she was in good health. Right after her first shot she started showing signs of dementia. Not long after she had some tests done which showed she had multiple small strokes. She was having trouble walking and needed a wheelchair. She had more tests done and it was found she was full of blood clots. We had a procedure done to stop one of the big clots in her leg but she died two days later. I looked up her batch numbers on a website and found that all of her lot numbers were a part of bad batches with multiple deaths and injuries. I believe Pfizer murdered my mother.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- I cannot remember what all tests she had, but I know she had at least one MRI. One of the hospitals is refusing to give me her records even of though I had MPOA prior to her death.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- She was dealing with some depression from the loss of her husband, but other than that, none that we know of.
- Andere Medikamente
- Aspirin, Bupropion HCL
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 26.02.2021
- Beginn
- 05.08.2022
- Tage bis Beginn
- 525,0
- Dosis
- 3
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
Abdominal pain
Acute respiratory failure
Anxiety
Aspiration pleural cavity
Asthenia
Blood alkaline phosphatase increased
Blood creatinine increased
Brain natriuretic peptide increased
COVID-19
Chemotherapy
Chills
Computerised tomogram abdomen abnormal
Confusional state
Death
Defaecation urgency
Delirium
Device leakage
Symptomtext
61y.o. female patient, with a past medical history of heart failure, hypothyroidism, malignant ascites, history of endometrial carcinoma peritoneal metastasis, coronary artery disease with NSTEMI history currently being treated at gynecological oncologist. Patient presented to the EC for evaluation for ongoing abdominal pain, nausea, a diarrhea that became intolerable beginning the night of 5/21. Patient attempted use of oral antiemetics without success, patient was unable to eat or drink. Her abdominal pain also became unmanageable at home, thus her presentation for urgent evaluation. She states she was having bowl urgency with soft stool, but denies any blood in bowel movements or urine. Patient denies fevers, chills, body aches, cough, chest pain/pressure/heaviness/palpitations, shortness of breath. Patient had a peritoneal drain placed on 4/15 which became infected, patient was treated for peritonitis related to enterococcus faecalis with IV antibiotics and discharged on PO linezolid. Patient was again recently admitted and discharged 5/17 - 5/20 for abdominal pain and leakage from old aspira drain site. On 5/18 a paracentesis was attempted but due to trace amounts of fluid, the procedure could not be completed. Patient had initiated chemotherapy with docetaxel, carboplatin and Avastin, and was hospitalized recently for carboplatin desensitization. During the course of hospitalization, paracentesis took place, and the patient had started to experience a new onset left-sided abdominal pain. CT scan abdomen and pelvis was acquired, which unfortunately was suggestive of further progression of disease, especially within the liver. Plan was to change treatment to gemcitabine and Avastin, with incorporation of Piqray. The patient, recently initiated treatment with gemcitabine and Avastin, and received a treatment on 7/26/2022, in addition to undergoing a round of paracentesis. The patient thereafter developed symptoms of nausea vomiting, and abdominal pain. Patient presented to EC on 8/5 for evaluation of abd pain, chills, SOB, leg swelling, nausea, and vomiting. Patient is positive for COVID currently in isolation. Patient had paracentesis yesterday. Overall patient statess she feels about the same, denies any chest pain pressure. Patient is currently on 3L NC and stable. 1. Nausea vomiting and abdominal pain and COVID -As delineated above, the patient presents with concerns regarding abdominal pain, nausea and vomiting, status post paracentesis, -Overall symptoms have improved with conservative measures. -Continue adequate pain control, and antiemetics at this time. -Currently in isolation for COVID, rec'd dose 1 of remdesivir this afternoon. -Did c/o severe itching w/o rash. Ordered hydralazine -HGB 8.7 Plts 153 -Patient anxious and uncomfortable. States she feels confused, talking to herself, having auditory and visual hallucinations. Consulted Dr for acute delirium -Patient states abd discomfort. Paracentesis ordered -WBC 14.2 ID following -Creat 1.17, IV hydration, nephro consulted -Denies any changes in shortness of breath. -Increase in ALK phos and LFT's. Associated with remdesivir -HGB 7.3 down 1g. Plts 353, stable. R/O hemolysis -Creat improved 1.03 from 1.17. -Appreciate psych's recs, positive for delirium, avoid benzo use. Seroquel 12.5 3 times daily for anxiety management. -Plan for paracentesis today -ID cleared patient for discharge -appreciate nephs recommendations. IV lasix 40mg bid, added albumin 25% 25 g TID x 5 days. Avoid large volume paracentesis, rec's once a week. -Appreciate medicine rec's - continue with supportive measures, IV antiemetics -Patient is not eligible for treatment and prognosis remains very poor. Our recommendation is to transition to comfort measures only and move forward with hospice. -Had extensive discussion with husband and patient. -Inquired regarding home hospice. Reviewed philosophy of hospice and palliative care. Patient and husband agreeable to home hospice at this time. -Placed stat hospice/palliative care/care management consult. -Will discharge home pending planning and coordination of care. -Had extensive discussion with family this morning. Overall prognosis is very poor. Patient is no longer eligible for treatment at this time. Husband was agreeable to hospice yesterday but had hesitations going home hospice due to the inability for the patient to receive as needed paracentesis. Patient overall status continues to significantly decline. At this time it is my opinion she is not eligible for ambulance transfer home for hospice. Patient was changed to no DNAR yesterday. Patient will remain inpatient until she passes. -comfort measures only Patient seems to be actively dying, moaning continue Robinul Dilaudid Ativan. 2. Metastatic endometrial carcinoma: High-grade serous: Poorly differentiated: Initially FIGO 3AT3AN0M0: Current progression of disease with peritoneal carcinomatosis: Bilateral pleural effusions: -Diagnosed with high-grade serous carcinoma of endometrium: high grade serous carcinoma of the endometrium FIGO IIIa (pT3aN0M0) s/p TAH-BSO, SLND and chemotherapy with Carbo/Taxol at Karmanos, patient follows Dr GynOnc. -High-grade poorly differentiated endometrial carcinoma initially stage Ia status post surgery March 10, 2021, subsequently got 6 cycles of carboplatinum and Taxol last cycle in August 2021 within 6 months had recurrence of pain in January and February CT showed progression and effusion. She started on lenvatinib however significant progression. Molecular testing has been done with Caris, no actionable mutation. Tumor mutation burden is 3 mismatch repair stable, PD-L1 negative. She has rare mutation RECQL4 which is not actionable at this time. -Progression of disease with peritoneal carcinomatosis and malignant ascites diagnosed 02/2022, currently on Keytruda and Lenvima. -Patient was started on carboplatinum along with docetaxel and Avastin weekly regimen. CT scan after completion of 2 cycles, was suggestive of progression of disease. -Status post initiation of gemcitabine, Avastin, with possible incorporation of Piqray. -The patient is currently modest of the first cycle, status post day 1 and 8 of treatments, with subsequent treatments to be resumed upon resolution of acute events. -Patient has not started piqray due to frequent hospitalizations. Now patient is terminal. Actively dying. 8/7 -Patient feeling tired today, denies fevers, and remains on 3L NC. -Some slight nausea but able to tolerate fluid and nutritional intake. -Will continue remdesivir dose 2/5 -Spoke with patient husband, updated plan of care 8/8 -Patient continues to remain stable on 3L NC. -Will complete remdesivir -CBC cmp reviewed. Remains stable 8/9 -Patient anxious and uncomfortable. States she feels confused, talking to herself, having auditory and visual hallucinations. Consulted Dr for acute delirium -Patient states abd discomfort. Paracentesis ordered -WBC 14.2 ID following -Creat 1.17, IV hydration, nephro consulted -Denies any changes in shortness of breath. 8/10 -Patient remains anxious and uncomfortable, has medications for anxiety -Denies and changes in respiratory status, stable on 3L NC -HGB 7.3 down 1g. Plts 353, stable. R/O hemolysis -Creat improved 1.03 from 1.17. -Appreciate psych's recs, positive for delirium, avoid benzo use. Seroquel 12.5 3 times daily for anxiety management. -Plan for paracentesis today -ID cleared patient for discharge -appreciate nephs recommendations. IV lasix 40mg bid, added albumin 25% 25 g TID x 5 days. Avoid large volume paracentesis, rec's once a week. -Appreciate medicine rec's 8/11 -Patient remains delirious, difficulty concentrating, falls asleep easily. -RRT'd this afternoon for respiratory distress, was found w/o her oxygen on. Husband updated. Patient transferred to progressive care. -HGB <7, 1 unit PRBC's given -Paracentesis today 8/12 -Patient doing much better since transferring to progressive care. -Patient states SOB has significantly improved -States she does not feel ready to go home. -CBC stable, HGB 9.2, Plts 339 8/13 -Patient seen and evaluated this AM, discussed with RN at bedside -Continue supportive measures 8/14 -Patient reports feeling nauseated this AM, IV antiemetics in place -Awaiting thoracentesis 8/15 - s/p thora. abd hard, plan paracentesis. - D/w ID. Dr Cannot get her off isolation , as per COVID policy yet. - Otherwise she feels better. 8/16 -Per ID, isolation for 20 days, today is day 14. -Family able to visit at bedside -Acute respiratory failure, on BiPAP earlier short amount of time, with AMS. Hypercarbia, refused BiPAP. -S/P paracentesis today 2L -Cardiac w/u this am abnormal Trops, BNP 1051. -2D echo EF 25%, new -Attempted left thoracentesis, fluid is loculated, attempt radiology -S/P right throa 8/14 700 cc -CBC stable HGB 10.0, plts 346 8/17 -Had extensive discussion with husband and patient. -Inquired regarding home hospice. Reviewed philosophy of hospice and palliative care. Patient and husband agreeable to home hospice at this time. -Placed stat hospice/palliative care/care management consult. -Will discharge home pending planning and coordination of care. -Thoracentesis done today 8/18 -Had extensive discussion with family this morning. Overall prognosis is very poor. Patient is no longer eligible for treatment at this time. Husband was agreeable to hospice yesterday but had hesitations going home hospice due to the inability for the patient to receive as needed paracentesis. Patient overall status continues to significantly decline. At this time it is my opinion she is not eligible for ambulance transfer home for hospice. Patient was changed to no DNAR yesterday. Patient will remain inpatient until she passes. -comfort measures only 8/20 Very weak fatigued, actively dying, Spent some time with the family. All family around the patient. Patient is moaning, actively dying. Continue Ativan, Dilaudid. Robinul. Discussed with the nurse. Actively dying. Date and time of death pronounced on 8/20/2022 at 2105.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 15,0
- Labordaten
- 8/5 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 03.01.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 122,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute kidney injury
Anaemia
Anticoagulant therapy
Asthenia
Atelectasis
Atrial fibrillation
Blood glucose increased
Bursa disorder
COVID-19
Cellulitis
Central venous catheterisation
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Culture wound
Echocardiogram
Echocardiogram normal
Electrocardiogram QT prolonged
Electrocardiogram abnormal
Symptomtext
Hospitalized (5.5-5.13.22), now in Sub-Acute Rehab; COVID-19 positive (5.5.22); Fully vaccinated PLUS booster BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: DO Admission Date: 5/6/2022 Discharge Date: May 13, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock (HCC) HOSPITAL COURSE: Patient is a 70-year-old male with past medical history of type 2 diabetes, rheumatoid arthritis, alcohol use disorder, right BKA, peripheral artery disease, atrial fibrillation who presented to the leading emergency department for generalized weakness, decreased oral intake, and fatigue for about a week. While in the ER he was found to be significantly hypotensive. He was given 3 L of IV fluids, antibiotics and required norepinephrine for blood pressure support. He was transferred to the intensive care unit for treatment of shock. Notably in the ER he had wounds to his coccyx, right knee and evidence of previous skin infections with healing rash throughout upper and lower extremities. He is also COVID positive. The patient's EKG showed a QTC of 710, for this reason his home amiodarone was held. The etiology of his prolonged QTC is unclear, it does appear he has had prolonged readings in the past but his only QT prolonging agent is amiodarone. Overall his initial presentation was concerning for sepsis. He has a history of immunosuppression with medications to treat his rheumatoid arthritis. He has been off these for about a month due to anemia which is also undergoing outpatient workup with Hematology, who think it may be due to bone marrow suppression. Workup for blood loss anemia so far has been inconclusive. Most recently on Rinvoq. The patient's echocardiogram was not indicative of a cardiac etiology for his shock. Patient had a CT of his chest abdomen pelvis which showed right greater than left lung consolidation, atelectasis, effusion as well as a CT of his right lower extremity that was negative for signs of soft tissue infection. He was treated with pressors, cefepime and vancomycin and fluids. He was started on EndoTool for glucose in the 300s. The patient showed clinical improvement, and was weaned off norepinephrine on his 3rd hospital day. Stress dose steroids were also stopped completely on this day, and EndoTool will be continued for the next 24 hours at least until glucose stabilizes and he can be switched to a basal/bolus regimen. A repeat EKG on his stay showed a QTC of 574 ms, down from 710ms on arrival. The patient has had no chest pain or other cardiac symptoms during this hospitalization. The patient central line is removed, and he is stable for transition to the hospital floor. Spoke with Cardiology as well as the hospitalist regarding anticoagulation for his atrial fibrillation / COVID-19 status verses possible blood loss anemia. Given the patient's anemia might be secondary to bone marrow suppression rather than acute blood loss, the benefits outweigh the risks for anticoagulation. He was started on a heparin infusion. The patient did consent to blood transfusion in the event that it is required. On 05/09, the patient is transferred from the ICU to the general floor. Hemoglobin remained stable. He was transitioned to Eliquis before discharge. In terms of his cellulitis, it improved significantly and he completed a course of antibiotics while inpatient. He was discharged to inpatient rehab in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Septic shock
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 4.6.22 - ED - Anemia 5.5.22 - admitted to hospital prior to being transferred DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shock (HCC) Shock liver AKI (acute kidney injury) (HCC) QT prolongation Septic shock (HCC) Anemia, unspecified type COVID-19 HOSPITAL COURSE: A patient presenting to the emergency room with septic shock. This was felt to be secondary to a soft tissue wound infection associated with the right suprapatellar bursa/knee. This wound and quite red and tender for 1 week and had broken open and was training. This was cultured in the emergency room. He was placed on broad-spectrum antibiotic therapy. Require vasopressor support and volume resuscitation with crystalloid and colloid. He presented with acute kidney injury and acute tubular necrosis and remain overgrowth discrete the following resuscitation. He was given 1 dose of IV Bumex today. He is being transferred to another Hospital for additional critical care management. Issue discussions with them.
- Vorgeschichte
- Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin (HCC) OSA (obstructive sleep apnea) Hyperlipidemia LDL goal <70 Alcohol abuse Broken bones Allergy history, latex Hayfever Osteomyelitis of second toe of right foot (HCC) Rheumatoid arthritis (HCC) Persistent atrial fibrillation (HCC) Rheumatoid nodule (HCC) Long-term use of high-risk medication Generalized osteoarthritis of multiple sites Non-ischemic cardiomyopathy (HCC) Chronic systolic heart failure (HCC) Essential hypertension S/P BKA (below knee amputation) unilateral, right (HCC) PAD (peripheral artery disease) (HCC) Rheumatoid arthritis involving multiple sites with positive rheumatoid factor (HCC) Microcytic hypochromic anemia Other specified anemias Elevated liver enzymes Low zinc level Long term current use of antiarrhythmic drug Coagulation defect (HCC) Nail avulsion, toe Open wound of right knee Prolonged QT interval Skin lesions COVID-19 virus RNA test result positive at limit of detection Alcohol dependence (HCC) Benign prostatic hyperplasia with lower urinary tract symptoms AF (paroxysmal atrial fibrillation) (HCC) Nonspecific abnormal electrocardiogram (ECG) (EKG) Pressure injury of deep tissue of left heel Pressure injury of sacral region, unstageable (HCC) Skin ulcer, limited to breakdown of skin (HCC)
- Andere Medikamente
- albumin human 25 % IV ascorbic acid (VITAMIN C) 1000 MG tablet atorvastatin (LIPITOR) 40 MG tablet bisacodyl (DULCOLAX) 10 MG suppository Calcium Gluconate-NaCl (CALCIUM GLUCONATE IN NACL 0.675%) 1 g/50 mL SOLN ceFEPIme (MAXIPIME) 1 GM/50ML
- Allergien
- Red Dye, Latex
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 02.05.2022
- Impfdatum
- 13.12.2021
- Beginn
- 14.04.2022
- Tage bis Beginn
- 122,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Agitation
Alanine aminotransferase increased
Ammonia increased
Angiogram pulmonary abnormal
Angiogram pulmonary normal
Anticoagulant therapy
Ascites
Aspartate aminotransferase increased
Atelectasis
Atrial fibrillation
Azotaemia
Bacterial test negative
Blood gases normal
Blood glucose increased
Blood pressure decreased
Blood thyroid stimulating hormone decreased
Symptomtext
Deceased (4.30.22); Hospitalized (4.14.22); COVID-19 positive (4.11.22-home test); Fully vaccinated plus booster - pfizer x3 4/15/22 pulm H&P: HPI: History obtained from the chart since patient was intubated in the ED. He presented with worsening shortness of breath in the setting of testing positive for COVID about 4 days prior. He was initially 89% on RA but HR was in the 160s, afib. He progressed to having more tachypnea and more respiratory distress so was eventually intubated. Upon arrival to the MICU patient's heart rate persisted in the 160s with evidence of LBBB. Blood pressure progressively dropped. ROS: unable to obtain due to mechanical ventilation and sedation FIO2 (%): 90 % Type of Mechanical Vent: Hamilton Mechanical Rate: 32 breaths/min Set/Target Tidal Volume: 500 PEEP (cm H2O): 14 cm H2O EPAP: 5 IPAP: 16 cmH2O Inspiratory Time Set: 0 second(s) Intubated, sedated No scleral icterus Moving air well anteriorly Abd soft No pitting LE edema Synchronous on the vent A/P: Acute hypoxic resp failure COVID pneumonia - Decadron 6mg daily - Supportive care with mechanical ventilation - Low tidal volume ventilation with goal Tv 4-6mL/kg. Target Dp <14 and Pplat <30 - Check D-dimer and CRP - Tocilizumab still on shortage - Needs bronch with BAL to guide de-escalation of antibiotics - Okay to continue empiric coverage for now Shock - Unclear etiology - Has known ischemic cardiomyopathy, last EF 55% from 2018 - Repeat echo - Stress dose steroids (hydrocortisone added in addition to Decadron for more mineralocorticoid effect) - Trial of IVF bolus, though no more than 1L due to resp failure - Check central venous O2 sat Afib with RVR Left bundle branch block History of ischemic cardiomyopathy - Discussed with Cardiology given concern for new LBBB. Appears to be rate dependent with improvement once rate controlled - Started on amio drip, will continue - aspiri - hold statin due to rising AST and ALT AKI - Likely due to shock/hypotension - Trend, avoid nephrotoxins, renally dose meds Elevated AST and ALT - Possibly due to hypotension - Trend - No statin History of HIT - no heparin products - Fondaparinux for DVT prophylaxis FEN/GI - fluid boluses as needed - potassium hemolyzed, repeat labs - NPO but assess with daytime team - Fondaparinux for DVT proph - PPI for GI proph FULL CODE This patient is critically ill and is requiring active support and intensive surveillance to prevent life threatening clinical deterioration. I spent a total of 80 minutes in the evaluation and management of this patient excluding all procedures 4/29/22 General Med Progress note:CHIEF COMPLAINT: Pneumonia due to COVID-19 virus ASSESSMENT / PLAN: 65-year-old man with a complex past medical history, including atrial fibrillation status post Watchman, heart failure with preserved ejection fraction, coronary artery disease, hypertension, type 2 diabetes, cirrhosis, history of HIT, as well as hyperlipidemia and alcohol use disorder. He presented with respiratory failure secondary to COVID-19 pneumonia; intubated from 04/15 through 4/19. Patient also had shock requiring pressors and stress dose steroids. Completed methylprednisolone through 04/24/2022. Remdesivir not completed secondary to elevated LFTs. Hospital course now complicated by toxic metabolic encephalopathy and delirium. Psychiatry following along. Likely multifactorial related to post intensive care unit stay, COVID-19, altered sleep-wake cycle, hepatic encephalopathy in setting of cirrhosis. Receiving Zyprexa. Patient also with acute kidney injury requiring hemodialysis and worsening respiratory distress/leukocytosis now being treated for possible secondary bacterial pneumonia. # Acute Hypoxemic Respiratory Failure Secondary to COVID-19 Pneumonia: # Leukocytosis and Possible secondary Bacterial Pneumonia (4/25) Patient vaccinated for COVID. Tested positive 4/11/2022. Intubated 4/15 through 4/19, but had been able to wean to room air. CT angiogram thorax 04/15/2022 extensive airspace disease bilaterally, no central, lobar proximal pulmonary embolism. Chest x-ray 04/19/2022, shallow inspiration concerning for congestive heart failure. Independently reviewed chest x-ray from 04/24/2022, clearing of the right lung base, limited his ability to the retrocardiac space, no definite infiltrates. Bronchoscopy completed 04/15/2022, cultures negative. Film array positive for COVID-19. Patient received dexamethasone 6 mg 04/15/2022, then received stress dose steroids changed to methylprednisone 60 mg daily from 04/17 to 4/24 to complete a 10 day course. Received remdesivir for single dose, but then held given elevated LFTs. Covid infection also complicated by AKI as discussed below Patient with worsening respiratory distress, rising WBC and elevated Procal (1.0) on 4/25. (Although prior procal 4.79 on 4/15). Started on IV cefepime and vancomycin (Renally dosed) due to concern for secondary bacterial PNA. -Procal down trending to 0.55 on 4/27 and although increased resp distress and requiring 4-5L O2 via NC on 4/27, CXR with improvement. Resp status stable on 4/28, but no improvement/change overall from day prior. -Started on vanc and cefepime for a 5 day course (EOT 4/29). - Continue incentive spirometry, prone positioning if able - Wean supplemental oxygen as able - DVT prophylaxis with Eliquis 2.5 mg twice daily given HIT history. Mobilize as able. # AKI: Currently hemodialysis dependent MWF. # Worsening Uremia with Dialysis catheter malfunction Nephrology consulted and following, appreciate their recs AKI suspected to be a ischemic acute tubular necrosis in the setting of shock. COVID-19 can also cause renal injury such as FSGS and thrombotic microangiopathy. Patient currently requiring intermittent hemodialysis for renal function and volume control. However, neph reporting they are having problems with his dialysis catheter. They attempted TPA his last 2 sessions without resolution. Was not able to attempt HD today. BUN elevated 138->162 on 4/29 PM. Pt becoming more altered. IR consulted to replace line with plan for HD session on 4/30 AM. Will continue to monitor renal function, electrolytes, and mental status closely. May need more urgent HD if any clinical worsening. (Was called to the bedside by RN this afternoon since pt much more somnolent. Reportedly only minimally responsive to pain/sternal rub. When I arrived, patient able to alert more to loud noises/slamming of the door. He was spontaneously making eye contact, but remained non-verbal and quickly falling back asleep.) Avoid nephrotoxic agents. Continue PhosLo with meals # AMS, Agitation - Suspect multifactorial related to Toxic Metabolic Encephalopathy (COVID 19/AKI)/Hepatic Encephalopathy, Post ICU Delerium, Steroid Use: Workup thus far includes CT head with no acute intracranial process, ammonia level elevated at 70, but lower since. TSH 1.2. Vitamin B12 normal. Vitamin B1 pending. VBG with no CO2 retention on multiple checks. EEG revealed mild-to-moderate background slowing, bitemporal slow waves, GRDA slow posterior dominant rhythm consistent with mild-to-moderate cerebral dysfunction and encephalopathy. No seizures were identified. Exam remains Nonfocal. No nuchal rigidity or headache reported. -Psychiatry consulted. Appreciate their recs - Pt with continued waxing/waning mental status - Continue with Zyprexa 5 mg daily and p.r.n. (Psych initially recommended increasing dose to BID, but given not taking PO meds consistently on 4/27 so continue current dose for now. Added PRN IM Zyprexa as alternative) - Continue Bilateral soft wrist restraints as needed (currently in place). - Continue IV thiamine 100mg daily given alcohol use history. Will continue lactulose 3 times a day and rifaximin 2 times a day (encouraged nursing staff to keep offering PO meds once mental status showing signs of improvement). Titrate lactulose to 3 loose stools per day. (If pt too agitated, would give lactulose rectal as needed) - AMS worsening 4/28-4/29 in setting of rising BUN and ineffective HD sessions as noted above #Decreased Responsiveness Episode Following HD (x2 episodes): Patient had some hypotension during hemodialysis 4/25 and again 4/27. Following that, patient had an episode of decreased responsiveness. By the time the team arrived at the bedside, patient was awake, interactive (happened both times). This does not appear consistent with acute CVA; however, stat head CT was ordered with initial episode and negative. Neurology was contacted. -Still plan to attempt MRI brain once patient less agitated and respiratory status improved. (Wife states pt with anxiety/claustrophobia at baseline to unlikely to tolerate MRI without some sedation.) - Repeated infectious work-up 4/25 with complete blood count (rising WBC), BMP, ammonia level (stable), lactic acid (neg), chest x-ray ordered to evaluate for alternative etiology of transient decreased responsiveness. CXR with worsening atelectasis vs infiltrate. Started on IV cefepime and vancomycin and treatment for secondary bacterial PNA and HAP as discussed above # New LBBB: Noted troponin elevation 39, repeating to 52. Appreciate cardiology input, prior to discharge ischemic cardiac workup is planned. # Transaminitis: Patient with significant elevation in AST 3571 and ALT 2029. LFTs have been trending down. Right upper quadrant ultrasound with Doppler reveals surface nodularity and hepatocellular disease. Small amount of ascites, portal venous hypertension. Gallbladder wall thickening and hepatic waveform in the liver can be seen with heart failure. Clinical trajectory seems most consistent with shock liver. Liver toxicity related to amiodarone also should be considered, though given the trajectory of the LFT elevation well amiodarone is being continued make this less likely. # Chronic HFpEF now with Acute Cardiomyopathy - Echo 4.22.22 EF 25% with global LV dysfunction with moderate to severe RV dysfunction. Pt was on BID IV Lasix 80 mg for volume control in addition to hemodialysis. Lasix held 4/27. 2 g sodium and 2 L fluid restriction. Appreciate cardiology input. # RV Dysfunction: Echocardiogram 4/22/22 revealed moderate to severe RV dysfunction. May need to consider PAH workup as well, with comprehensive ECHO. CTA showed no Pulmonary Embolism. Discussed with Cardiology and at this point, we are holding off on further cardiac evaluation until patient is approaching discharge. # Shock: resolved. Etiology was not clear, pan cultures negative. Patient received stress dose steroids, and vasopressin and norepinephrine have been discontinued since 04/19/2021. Shock has resolved. # Liver Cirrhosis: MELD 26. Currently decompensated. Right upper quadrant ultrasound completed as outlined above, revealing cirrhosis. Continue lactulose for hepatic encephalopathy with rifaximine. Small amount of ascites, likely too small to pursue safe paracentesis, no abdominal pain. Monitor INR, LFTs daily. Spironolactone on hold # Afib with RVR: Chads Vasc is 3. Patient status post Watchman. Given amiodarone load and now on amiodarone 200 mg daily. Rate control currently acceptable. Continue metoprolol at 50 mg 3 times a day. (If patient remains altered and unable to tolerate PO meds, will transition back to IV) Will defer resuming digoxin to the cardiology team. # Elevated D-Dimer: Significant elevation to 12,000 on admission. CT angiogram revealed no evidence of pulmonary embolism. Upper and lower extremity ultrasounds were obtained which did not reveal DVT. Patient was empirically on a agatroban, this has been discontinued by the critical care team. Initiated on Eliquis 2.5 mg twice daily for DVT prophylaxis given the patient is unable to receive fondaparinux given renal function. # Previous HIT: Avoid all heparin products. # Visual Hallucinations: Seem resolved # DM2: Goal blood sugar 140-180. Patient remains above goal with variable oral intake in the setting of AMS. Glu up to 500s on 4/28 PM, now improving to 200s. Management per the endocrinology team. # HTN: Continue metoprolol 50 mg every 8 hours. If pt consistently altered/refusing PO meds, will transition to IV metoprolol. # HLD/CAD: Aspirin, holding statin given elevated LFTs. Non-invasive ischemic workup closer to DC # Urinary Retention: improved Straight cath PRN #Limited oral intake #Deconditioning: Oral intake remains poor. Started on calorie count 4/28 Wife considering enteral nutrition/ corpak placement if needed. However, will continue to monitor oral intake. Continue PT and OT, consider acute rehab as he approaches discharge. # Hyperphosphatemia: Continue Phoslo. Continue daily creatinine, complete blood count with differential, and liver function lab monitoring while on IV antibiotic (vancomycin and cefepime) to monitor for renal, myelotoxicity, and hepatoxicity. SUBJECTIVE/Interval History: Patient remains much more somnolent and altered than days prior. Discussed with Nephrology this morning. Patient has been having problems with his dialysis catheter this entire week. They attempted to tPA the line the last 2 dialysis sessions; however, they continued to have problems. Patient's labs remain concerning, with rising BUN level. Concerned that this is likely contributing to his altered mental status. Patient was not able to complete any of his HD session this morning. IR was consulted for line replacement, but due to emergent cases, this may not be completed until tomorrow morning. Son at the bedside was very concerned regarding patient's mental status. I discussed patient's abnormal lab results and how this was not too unexpected. We reviewed patient's previous chest x-rays, CT chest, and earlier hospital imaging at the bedside. Noted overall improvement in patient's imaging. Answered son's additional questions and reassured him of plans of care. OBJECTIVE: BP 149/91 | Pulse 84 | Temp 36.9 ?C (Axillary) | Resp 26 | Ht 1.88 m | Wt 107 kg | SpO2 100% | BMI 30.29 kg/m? FIO2 (%): 25 % Physical Exam Constitutional: General: He is in acute distress. Appearance: He is ill-appearing. He is not toxic-appearing. Comments: Somnolent HENT: Head: Normocephalic. Nose: No congestion or rhinorrhea. Mouth/Throat: Mouth: Mucous membranes are dry. Comments: Resting primarily with mild gaping open, mucous membranes dry Eyes: General: No scleral icterus. Extraocular Movements: Extraocular movements intact. Conjunctiva/sclera: Conjunctivae normal. Neck: Comments: R IJ catheter place Cardiovascular: Rate and Rhythm: Regular rhythm. Tachycardia present. Pulses: Normal pulses. Heart sounds: No murmur heard. Pulmonary: Effort: Respiratory distress present. Breath sounds: Rales present. No wheezing. Comments: Diminished at b/l bases with a few faint crackles (L>R), mild tachypnea with increased subcostal retractions compared to day prior, intermittent stertorous breath sounds, protecting airway in maintaining saturations on 5 L O2 via nasal cannula Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: No tenderness. Cervical back: Neck supple. Comments: 1 to 2+ proximal hip edema, trace bilateral leg edema Skin: General: Skin is warm and dry. Capillary Refill: Capillary refill takes less than 2 seconds. Neurological: Mental Status: He is disoriented. Comments: Somnolent but did spontaneously open eyes and track intermittently, nonverbal today, quickly falls back asleep
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Past Medical History: Diagnosis Date ? Acute hepatitis 2009 ? Acute MI ? Acute respiratory failure 2009 ? Alcohol abuse ? Arthritis ? Atrial fibrillation ? Cardiomyopathy low EF, ETOH in past, now 55% in 2019 ? Diabetes mellitus type 2 in obese ? DVT (deep venous thrombosis), bilateral 2009 ? HIT (heparin-induced thrombocytopenia) ? Hyperlipidemia LDL goal <100 statins made him achy ? Pneumonia 2009 ? Presence of Watchman left atrial appendage closure device ? Renal insufficiency r/t heparin reaction
- Andere Medikamente
- Aspirin 81 mg Oral Daily Carvedilol 25 mg Oral 2 times daily Melatonin 10 mg Oral Nightly metFORMIN HCl 500 MG TAKE 1 TABLET BY MOUTH TWICE DAILY. INCREASE TO 2 TABLETS BY MOUTH TWICE DAILY BY WEEK 2 Omega-3 Fatty Acids 1 g 2 times daily Si
- Allergien
- heparin - HIT penicillins - not specified
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 17.12.2021
- Beginn
- 12.01.2022
- Tage bis Beginn
- 26,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Blood sodium abnormal
Bronchitis
Cardiac failure acute
Left ventricular failure
Polyuria
Urinary retention
Symptomtext
Acute hypoxic respiratory failure secondary to acute on chronic diastolic - Patient was subsequently admitted and diuresed with IV Lasix. Her sodium did improve to 129 on day of discharge. She was back on room air. She did require oxygen at night. Patient reports she has oxygen at home. In regards to her bronchitis she was treated with oral prednisone. Urine retention did resolve. And day of discharge, patient again reported feeling well. Therapies were recommending home without services. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 12.01.2021
- Beginn
- 14.02.2022
- Tage bis Beginn
- 398,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Patient died after contracting COVID-19 Feb 7, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 14.10.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 22,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Coronary angioplasty
Coronary arterial stent insertion
Coronary artery occlusion
Symptomtext
STEMI - Was taken to the Cath Lab from the ED. S/p stenting of 1st Diag (which was 100% occluded), angioplasty w stenting of mid LAD and mid PDA. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 15.02.2022
- Impfdatum
- 13.12.2021
- Beginn
- 21.01.2022
- Tage bis Beginn
- 39,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Fully vaccinated with two doses of Pfizer. Tested positive for COVID 19 on 01/21/2022. Admitted to the hospital on 01/21/2022. Expired on 02/06/2022 while still hospitalized.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 17.01.2022
- Impfdatum
- 16.12.2021
- Beginn
- 13.01.2022
- Tage bis Beginn
- 28,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Hyperglycaemia
SARS-CoV-2 test positive
Type 2 diabetes mellitus
Symptomtext
Patient received Pfizer COVID vaccine on 4/17/21 (lot EW0164), 5/8/21 (lot EW0182), and 12/16/21 (lot FD0810). From 1/13/22 to 1/15/22, patent was admitted to our inpatient med/surg unit for uncontrolled type 2 diabetes with hyperglycemia and COVID-19 infection with possible superimposed bacterial pneumonia (relatively asymptomatic during this hospitalization). On 1/16/22, patient was re-admitted to the hospital with acute respiratory failure with hypoxia and pneumonia due to COVID-19 virus. As of today (1/17/22), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- COVID status positive 1/13/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ESRD on peritoneal dialysis, history of renal transplant, DM2, hypertension, hyperlipidemia, hypothyroidism
- Andere Medikamente
- amlodipine, baby aspirin, atorvastatin, calcitriol, cefpodoxime, furosemide, insulin glargine pen, insulin lispro pen, losartan, magnesium oxide, methimazole, metoprolol, mycophenolate, omeprazole, prednisone, tacrolimus
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Immunisation
Symptomtext
Patient died approximately 20 minutes after receiving booster dose.; booster dose; This is a spontaneous report received from contactable reporter (Pharmacist). The reporter is the patient. A 92-year-old female patient (not pregnant) received bnt162b2 (PFIZER COVID-19 VACCINE), intramuscular, administered in arm left, administration date 29Oct2021 09:10 (Lot number: FD0810) at the age of 92 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Chronic pain"; "GERD"; "HTN"; "DM II"; "hx DVT"; "hx. malignant neoplasm of other digestive organs"; "activated protein C resistance"; "hx of malignant neoplasm of breast"; "hx malignant neoplasm of other parts uterus"; all unspecified if ongoing. It was unknown if patient diagnosed with COVID-19 prior vaccination. Patient had not been tested for COVID-19 post vaccination. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included: chlorthalidone; ergocalciferol (VIT D); acetaminophen; omeprazole; metoprolol tartrate (LOPRESSOR); metformin; tramadol; plantago ovata (METAMUCIL); insulin lispro (HUMALOG); warfarin; kcl. Past drug history included: Morphine, reaction: "Known allegies: Morphine"; Meperidine, reaction: "Known allegies: Meperidine"; Metoprolol, reaction: "Known allegies: Metoprolol"; Lisinopril, reaction: "Known allegies: Lisinopril"; Aleve, reaction: "Known allegies:Aleve"; Altace, reaction: "Known allegies:Altace"; Boniva, reaction: "Known allegies:Boniva"; Doxycycline, reaction: "Known allegies:Doxycycline"; Oxycodone, reaction: "Known allegies:Oxycodone". Vaccination history included: Bnt162b2 (Dose Number: 2, Lot No: EL9269, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 09Feb2021, when the patient was 91 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Lot No: EJ1686, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 19Jan2021, when the patient was 91 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (death) with onset 29Oct2021, outcome "fatal", described as "booster dose"; DEATH (death, medically significant) with onset 29Oct2021 09:30, outcome "fatal", described as "Patient died approximately 20 minutes after receiving booster dose". Therapeutic measures were not taken as a result of death. The patient date of death was 29Oct2021. The reported cause of death was "Patient died approximately 20 minutes after receiving booster dose". No autopsy was performed. Clinical course: Patient died approximately 20 minutes after receiving booster dose.; Sender's Comments: Based on the limited information available and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events immunization and death cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Patient died approximately 20 minutes after receiving booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Activated protein C resistance; Chronic pain; DVT; Gastrointestinal neoplasm malignant; GERD; Hypertension; Malignant neoplasm of uterus, part unspecified; Neoplasm breast; Type 2 diabetes mellitus
- Andere Medikamente
- CHLORTHALIDONE; VIT D [ERGOCALCIFEROL]; ACETAMINOPHEN; OMEPRAZOLE; LOPRESSOR; METFORMIN; TRAMADOL; METAMUCIL [PLANTAGO OVATA]; HUMALOG; WARFARIN; KCL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Immunisation
Symptomtext
died in 30 to 35 minutes after; booster; This is a spontaneous report from two contactable pharmacists. Three serious adverse events occurred after administration of Pfizer booster doses just in the past 5 days from one pharmacy location and all have been from the same Lot# FD0810 of Pfizer product. This is one of three cases. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, COVID 19 Vaccine, mRNA, purple cap), dose 3 via an unspecified route of administration on an unspecified date (Lot Number: FD0810; Expiration Date: 30Nov2021) as dose 3 (booster), single for COVID-19 immunization. Medical history and concomitant medications were not reported. Historic vaccine was 1st and 2nd dose of bnt162b2 (lot unknown) received for COVID-19 immunization. The patient died in 30 to 35 minutes after on an unspecified date. It was not reported if an autopsy was performed. The outcome of event was fatal.; Sender's Comments: The information provided is limited and does not allow a meaningful medical assessment of the case. However, based on the available information in the case, a possible contributory role of the suspect product BNT162B2 to the development of reported fatal events of Unknown cause of death and Booster cannot be completely excluded. The case will be reassessed further upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101489288 same reporter/drug/AE, different patient.;US-PFIZER INC-202101489289 same reporter/drug/AE, different patient.; Reported Cause(s) of Death: died in 30 to 35 minutes after; booster
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient passed away 20 to 30 minutes after vaccination unsure if related to vaccine or not
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hyperlipidemia; diabetes mellitus; gerd without esophagitis; dvt in lower extremity
- Andere Medikamente
- Acetaminophen 650mg po tid; Humalog Insulin sliding scale; Potassium 20meq po daily; Metformin 1000mg po bid; Chlorthalidone 12.5mg po daily; metoprolol tartrate po bid; omeprazole 20mg po daily; tramadol 50mg po tid and q 8 hours prn; war
- Allergien
- doxycycline; meperidine; morphine; ibandronate; lisinopril; naproxen
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 10.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cardiac monitoring normal
Echocardiogram normal
Ischaemic stroke
Symptomtext
Patient received her first booster on Jan 10, 2022 and had a acute ischemic stroke on March 24, 2022. Patient Spent a couple of days at Hospital and was discharged. No cause of the stroke was found. No blockage, no blood vessel problems, Damage to brain noted Patient is now on three new maintenance prescriptions for standards of care for stoke patients.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- 2,0
- Labordaten
- Echo cardiogram was performed. No problems noted. Heart was monitored with electronic device for two weeks. No AFib or irregular heart episodes.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Lisinopril, multi vitamin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 11.12.2021
- Beginn
- 26.05.2022
- Tage bis Beginn
- 166,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Adenovirus test positive
Adrenal insufficiency
Asymptomatic COVID-19
Bladder catheterisation
Blood sodium increased
Body temperature increased
COVID-19
Chest X-ray normal
Condition aggravated
Diabetes insipidus
Hypervolaemia
Hypotension
Hypovolaemic shock
Intensive care
Pyrexia
SARS-CoV-2 test positive
Sepsis
Shock
Symptomtext
Hospitalized (5.26.22); COVID-19 positive (5.26.22); fully vaccinated PLUS booster BRIEF OVERVIEW: Primary Care Physician at Discharge: MD Admission Date: 5/26/2022 Discharge Date: 5/31/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetes insipidus (HCC) [E23.2] Adrenal insufficiency (HCC) [E27.40] Acute febrile illness in child [R50.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9] Sepsis (HCC) [A41.9] Hypovolemic shock (HCC) [R57.1] HOSPITAL COURSE: Overall Assessment: The patient is a 17 y.o. female with PMHx significant for spastic quadriplegic CP, hydrocephalus with VP shunt, epilepsy, schizencephaly, septo-optic dysplasia, 3rd nerve palsy, diabetes insipidus, adrenal insufficiency, secondary amenorrhea, g tube dependence,slow-transit constipation, short stature, global developmental delay, disordered sleep, and aggressive behavior who presented with fever and increased urine output, admitted to the PICU for steroid and fluid refractory shock. Respiratory/ENT: Patient remained on room air throughout her hospitalization Cardiovascular: Her multiple episodes of hypotension throughout her admission. She initially received to 60 mL per kg bolus of IV fluid. She was started on epinephrine and vasopressin both of which were eventually weaned off. She was dosed with stress dose steroids with 50 mg of hydrocortisone followed by 12.5 mg every 6 hours. Eventually she was weaned off the epinephrine. He was attempted to wean her onto her home dose of steroids but she did require further boluses of normal saline. This was likely secondary to her diabetes insipidus and excessive urine output. She will have a steroid taper at discharge. Her DDAVP was uptitrated throughout her hospitalization. Renal/Genitourinary: Patient was initially excessively fluid positive due to her shock. Following multiple doses of DDAVP and dose titration she was nearly euvolemic upon discharge. She did have a Foley catheter for urine output measured. FEN/GI: Patient's sodium levels fluctuate throughout her course. Upon discharge her sodium had been between 140 and 150 for multiple days. Her tube feeds were restarted after initially being held. Infectious Disease: Patient noted to be COVID + last week of April, asymptomatic at that time. Again tested positive on admission. Unclear if active COVID infection vs viral shedding. Noted to have rectal temp to 105.8 prior to admission. Film array positive for adenovirus and COVID 19. UA not suggestive of UTI. No focal consolidation on CXR. Possible related to MISC with prior COVID infection noted. Vanc and CTX started in the ED. Received 48 hours of empiric rocephin, cultures no growth to date, MISC workup noncontributory. Mom is also COVID positive with new symptoms. Endocrine: patient has a history of diabetes insipidus as well as adrenal insufficiency. See the above for stress dose steroid dosing. She require titration of her DDAVP prior to discharge. Discharge instructions have her taking 50 mcg of DDAVP at night and 100 mcg in the morning. Prior to admission she was taking at 50 mg nightly. We will have a 5 day steroid taper with hydrocortisone. These instructions were provided to the patient. Neurologic/Pain/Sedation/Psych: Throughout her hospitalization room we continued her home antiepileptic medications as well as her baclofen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypovolaemic shock
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- 3rd cranial nerve palsy, left Schizencephaly (HCC) Aggressive behavior Developmental delay Absence of septum pellucidum (HCC) Microcephaly (HCC) Epilepsy (HCC) Essential hypernatremia Dysphagia, s/p gastrostomy Septo-optic dysplasia (HCC) History of neurological testing - DO NOT EDIT Short stature Neuromuscular scoliosis Gastrostomy tube dependent (HCC) Adrenal insufficiency (HCC) Diabetes insipidus (HCC) Complex care coordination Strabismus Hydrocephalus s/p VP shunt Spastic quadriparesis (HCC) Septic shock (HCC) Agitation Sleep disturbance Slow transit constipation Dental caries, unspecified Secondary amenorrhea Vaccination not carried out because of caregiver refusal Incontinence of feces Muscle spasticity Moderate intellectual disabilities Childhood behavior problems Onychomycosis of great toe Skin lesion of back
- Andere Medikamente
- baclofen (LIORESAL) 10 MG tablet desmopressin (DDAVP) 0.1 MG tablet desmopressin (DDAVP) 0.1 MG tablet desmopressin (DDAVP) 0.1 MG tablet Enteral Nutrition Supplies MISC hydrocortisone (CORTEF) 10 MG tablet hydrocortisone (CORTEF) 5 MG tabl
- Allergien
- Vancomycin - rash Latex
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 16.04.2022
- Impfdatum
- 04.11.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Vaccination failure
Thrombosis
Symptomtext
Nasal Swab: Positive; Nasal Swab: Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old male patient received BNT162b2 (BNT162B2), on 14Oct2021 as dose 1, single (Lot number: FD0810 BUD), in left arm and on 04Nov2021 as dose 2, single (Lot number: FD0810 BUD) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Nasal Swab: Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Nasal Swab. Clinical course: The patient did not have any previous vaccines. The patient did not have other medications in two weeks. The patient did not have covid prior to vaccination. The patient was tested for covid-19 post vaccination. No follow-up attempts are needed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Name: Covid test; Test Result: Positive ; Comments: Nasal Swab
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 10,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Computerised tomogram
Confusional state
Electrocardiogram
Electroencephalogram
Lethargy
Seizure
Symptomtext
Evening of 16 January patient with no family history and no recent trauma, suffered seizure resulting in emergency transport to ER. Event was preceded by extreme lethargy & confusion. All blood work was clean, blood sugar was normal, no infections, no pregnancy, no drug or alcohol use. CT was ran, results on file ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Blood draws. Cat Scan. EKG/EEG
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- birth control
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 10.01.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anal incontinence
Dyskinesia
Paralysis
Symptomtext
Palsy, loss of body control, loss of bowel control
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 08.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 08.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Loss of consciousness
Pallor
Symptomtext
Pt felt light headed and got pale then lost consciousness briefly
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 28.12.2021
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Vomiting
Symptomtext
patient passed out in the waiting room after vaccination and vomited after standing up. pharmacist gave patient water, granola bar, and had patient elevate legs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- passed out
- Staat
- OH
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 20.12.2021
- Impfdatum
- 20.12.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
Normal vaccine booster given. No blood at time of injection. Patient went to waiting area and sibling came in for her dose. I came out of area to find patient on the ground due to fainting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Fasting for physical earlier in morning
- Vorgeschichte
- No
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 29.10.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Hyperhidrosis
Loss of consciousness
Symptomtext
The patient was given the first dose of the Pfizer Covid vaccine. He was instructed to sit in a chair in the waiting area in front of the pharmacy for 15 minutes. Within minutes, one of the technicians alerted us that he was having some problems, and when I came out of the pharmacy, his head was slumped to the side. By the time I reached him, he was sitting up and talking to me. His wife came up and said he has had issues passing out after vaccines and having blood drawn before. My pharmacy manager went to get him something to drink hoping that would help him. He was sweating. He then lost consciousness again, and I called 911. I sent a technician after an employee that works on our front end that is a paramedic/fireman. He came and checked him out until the ambulance got here. They took to hospital via ambulance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- I do not have this information
- Vorgeschichte
- I do not have this information
- Andere Medikamente
- I do not have this information
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 27.10.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cold sweat
Dizziness
Pain
Syncope
Symptomtext
Patient experience dizziness and eventual syncope around 10-15 minutes after receiving 2nd dose of Pfizer COVID-19 vaccine. Patient came to after a few seconds and experienced usual post syncope symptoms (lightheadedness, cold sweats, body soreness, etc). Patient sat in pharmacy for approximately 30 minutes post event and sipped on orange juice and water while eating a few crackers. Patient was able to walk to car under her own power with her family and went home. Pharmacy will follow up with patient later today to check for any other symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None that we are aware of
- Vorgeschichte
- None that we are aware of
- Andere Medikamente
- None that we are aware of
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 14.10.2021
- Impfdatum
- 11.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood alkaline phosphatase increased
Blood creatinine normal
Chest pain
Ejection fraction normal
Electrocardiogram ST segment elevation
Laboratory test
Metabolic function test
Myocarditis
Painful respiration
Pericarditis
Troponin I increased
Symptomtext
Patient presented with left sided chest pain about 12-24 hours after the administration of the first vaccine. He had chest pain that worsened with respirations. Laboratory studies included elevated troponin levels consistent with myocarditis. A 15-lead electrocardiogram showed pericarditis. By 48 hours the patient had reduction in pain while being treated with ibuprofen, 400 mg by mouth 3 times daily. 3 days after the vaccination he received an echocardiogram showing normal left ventricular function.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- laboratory studies included a normal comprehensive metabolic panel with the exception of a creatinine at 0.6, alkaline phosphatase at 245. Troponin I was seeing road 0.088 ng/mL (laboratory reference range less than or equal to 0.040 ng/mL). 15-lead electrocardiogram performed on 10/14/2021 showed normal sinus rhythm with a rate of 70 bpm. PR interval 142 ms. QRS 94 ms, QTC 434 ms. Normal axis at 69?. There was generalized ST segment elevation consistent with pericarditis. There was possible left ventricular hypertrophy based on voltage criteria. A complete echocardiogram performed on 10/14/2021 showed normal intracardiac anatomy. Both coronary arteries were normal in size without evidence of ectasia and or aneurysm formation. The function was hyperdynamic with a left ventricular fractional shortening of 42% and ejection fraction of 73%. There was no pericardial effusion.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Mild intermittent asthma
- Andere Medikamente
- Albuterol HFA inhaler, as needed basis
- Allergien
- No know allergies
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Asthenia
Blood test normal
Computerised tomogram normal
Confusional state
Heart rate decreased
Head injury
Seizure like phenomena
Syncope
Pallor
Seizure
Symptomtext
6-8 minutes after injection my son passed out and fell on floor. He was extremely pale and having convulsions for 3-5 minutes until he came to and was very confused and weak. The paramedics arrived about 10 minutes after and his blood pressure was 70/30 and very slow pulse. They tried to sit him in a chair and he passed out again. They transported him to the hospital in an ambulance to the ER. The ER doctors did blood work and a CT which came back good. He was orthostatic positive for hours until he finally started having good results on the monitors and was released around 9pm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure like phenomena
- Hospital-Tage
- -
- Labordaten
- 10/8/2021 Blood test-normal CT- normal Blood pressure 70/30
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 03.10.2021
- Impfdatum
- 30.09.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arrhythmia
Atrioventricular block second degree
Cardiac pacemaker insertion
Computerised tomogram abdomen normal
Computerised tomogram head normal
Computerised tomogram thorax normal
Echocardiogram normal
Electrocardiogram abnormal
Full blood count normal
Platelet count normal
Syncope
Troponin normal
Symptomtext
heart block - type II AV nodal, with syncope, requiring pacemaker insertion on 10/1/2021. Syncope resolved but arrhythmia persists under pacemaker control
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 1,0
- Labordaten
- 10/1/2021: EKG showing type II AV nodal heart block. Echocardiogram - no evidence cardiac dysfunction or pericarditis. No evidence of myocardial ischemia on EKG or with troponin measurement. CT head, chest, abdomen all negative, without evidence of pulmonary embolism. Blood count normal, including platelet count.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- fexofenadine, nasal mometasone
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 31.08.2021
- Impfdatum
- 28.08.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Dizziness
Electrocardiogram
Feeling cold
Hyperhidrosis
Hypoaesthesia
Nausea
Seizure
Symptomtext
A couple moments after receiving my 1st covid vaccine I began experiencing dizziness, numbness in my face, couldn't feel my left leg for 30 minutes, went into convulsions for 20 minutes. They kept me for over an hour. Since then I have had chest pains almost all day each day, I have been dizzy, nauseous and back and forth between freezing and sweating.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- ECG today: August 31, 2021- Results came back ok for my heart. Doctor believes the convulsions caused muscle pain.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Asthma
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 30.03.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 77,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypotension
Symptom recurrence
Symptomtext
HYPOTENSION 6/18/2022 -- RECURRENCE OF SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 05.04.2023
- Impfdatum
- 14.10.2021
- Beginn
- 27.12.2022
- Tage bis Beginn
- 439,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
Bronchiolitis
COVID-19
Chills
Dyspnoea
Productive cough
SARS-CoV-2 test positive
Symptomtext
Patient presented to the ED by EMS on 12/27/22 with shortness of breath, productive cough, chills, and weakness for the past three days. EMS reports O2 of 85% on room air. He was placed on 3L nasal cannula. A COVID PCR test performed in the ED resulted positive. Patient was admitted 12/27/22 - 12/30/22 with discharge diagnoses including moderate to severe COVID-19 and acute COVID-19 bronchiolitis, among other diagnoses. During admission he was able to be weaned off supplemental O2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.03.2023
- Impfdatum
- 16.12.2021
- Beginn
- 10.02.2023
- Tage bis Beginn
- 421,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Atrioventricular block second degree
Bradycardia
COVID-19
Catheterisation cardiac abnormal
Chest tube insertion
Condition aggravated
Coronary artery bypass
Coronary artery disease
Cough
Dyspnoea
Echocardiogram abnormal
Haemoglobin decreased
Hypertension
N-terminal prohormone brain natriuretic peptide increased
SARS-CoV-2 test positive
Troponin increased
Ventricular hypokinesia
Symptomtext
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/10/2023 Discharge Date: 2/27/2023 PRESENTING PROBLEM: NSTEMI (non-ST elevated myocardial infarction) CAD in native artery HOSPITAL COURSE: Patient is a 78 y.o. who on 2/9 presented to outside hospital with complaints of cough and worsening dyspnea. She had elevated troponins, nT proBNP, and +covid. She was transferred. 2nd degree AVB was present. Cardiac cath demonstrated severe multivessel CAD. Her echo demonstrates LVEF 55%, with basal inferior and basal inferolateral wall segments appearing severely hypokinetic. Previous medical history includes HTN, DM2, HLD, CVA in 2018, brain surgery for meningioma in 2005 and 2015, seizure disorder. CABG scheduled pending Plavix washout. 2/20 CABG 2/21: Holding betablocker for bradycardia, transfer to 7H 2/22: Start low dose beta blocker, increase activities. Remove cordis and left mediastinal chest tube this PM. 2/23; Remove pacer wire and all chest tubes. CXR in AM. Increase activities. Anticipate discharge in 1-2 days. 2/24: All surgical tubes removed. Increase activities. Trending hypertensive, adjust blood pressure medications. 2/25: Hemoglobin 7.9 today, recheck H&H 2/26: NSR/SB overnight, HR in the 40s. Stop beta blocker and monitor HR overnight. Anticipate home tomorrow if no significant bradycardia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 17,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hyperlipidemia Seizures Hypertension Type 2 diabetes mellitus without complication GERD (gastroesophageal reflux disease) Lichen sclerosus et atrophicus of the vulva Anxiety NSTEMI (non-ST elevated myocardial infarction) Epilepsy COVID ASHD (arteriosclerotic heart disease) Acute on chronic systolic heart failure Chronic kidney disease (CKD), stage III (moderate) History of CVA (cerebrovascular accident) Pneumonia Acute blood loss as cause of postoperative anemia Bradycardia Pleural effusion
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 40 MG tablet betamethasone dip
- Allergien
- PenicillinsRash
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 16.03.2021
- Beginn
- 14.12.2022
- Tage bis Beginn
- 638,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
12/14/22 presents to EC ED for "shortness of breath". PMHx of "Crohn's with ostomy"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 12/15/22 SARS-CoV-2 (COVID-19) detected.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 20.10.2021
- Beginn
- 21.11.2021
- Tage bis Beginn
- 32,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Dyspnoea
Respiratory tract congestion
Surgery
Symptomtext
Around a month after the vaccine, I was waking up in the mornings congested. Off and on congestion that I normally did not have. I am still having those issues right now. It has been a year since October 2021 that I have been having congestion issues. It has gotten worse. It could be allergies. I don't know if it is allergies. I don't know where it came from. I saw my primary care in 11/2021, doctor and they gave me Z-pak. I went to my ENT doctor as well on 11/19/2021. I don't feel like I should be getting these Z-pak this often. Now I am trying to go to a lung specialist because I am having problems with my breathing and congestion. I had Turbinate surgery in 1/2022. I got COVID-19 in early 2021 and 8/27/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Turbinate surgery
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- high blood pressure; Sinus issues; Acid reflux
- Andere Medikamente
- Claritin
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 17.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Headache
Injection site pain
Mobility decreased
Pyrexia
Symptomtext
That same day of the vaccine my arm burned when they put it on me and then became normal, at night I had a little fever and could not move my arm. On the 7th day, I got a burning feeling in the head, I called my daughter, and I took liquid ADVIL of 200 mg, and the burning was removed and then days after since then I continue with that burning permanently in the head. I suffer from migraine and burning is different from pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Asthma; Depression
- Andere Medikamente
- Clonazepam; Atorvastatin; Sertraline; Metformin; Montelukast; Amitriptyline; Temazepam; Vitamin D; Flovent
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 07.09.2022
- Impfdatum
- 01.10.2021
- Beginn
- 05.07.2022
- Tage bis Beginn
- 277,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Atrial fibrillation
Cardiac monitoring
Dyspnoea
Echocardiogram
Electrocardiogram abnormal
Scan
Symptomtext
AFIB, 3 trips to ER due to shortness of breath. Amiodarone Hydrochloride for heart, Eliquis for blood thinner.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- EKG (AFIB), heart monitor, Echocardiogram, Nuclear lexiscan.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- No prescriptions. Centrum silver men 50+, fish oil, vitamin D3, B12, C, glucosamine & chondroitin.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 15.12.2021
- Beginn
- 24.08.2022
- Tage bis Beginn
- 252,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Alcohol poisoning
Asymptomatic COVID-19
Blood ethanol increased
Blood lactic acid
COVID-19
Chest X-ray abnormal
Computerised tomogram head normal
Laboratory test normal
Lactic acidosis
Lung opacity
Pneumonia
Procalcitonin normal
SARS-CoV-2 test positive
Symptomtext
PRESENTING PROBLEM: Acute alcohol intoxication, with unspecified complication (HCC) [F10.929] Alcoholic intoxication without complication (HCC) [F10.920] Community acquired pneumonia of right lower lobe of lung [J18.9] COVID-19 virus detected [U07.1] HOSPITAL COURSE: The patient is a 67-year-old female with history of dementia and alcohol abuse who presented to the emergency department acutely intoxicated from her independent living facility. Labs were stable in the emergency department. Lactic acid was elevated to 3.1. The patient was positive for COVID. Ethanol level was 426. Chest x-ray showed a right basilar lung opacity. IV antibiotics were started. The patient was admitted for further continuation of care. Antibiotics were stopped on admission. The patient's procalcitonin level was unremarkable. CT head was negative for an acute process. Her mentation improved. She was alert and oriented x4 the day of discharge. Her lactic acidosis resolved with IV fluid hydration. She was asymptomatic from a COVID-19 perspective. Social work evaluated the patient. She was discharged back to independent living in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Current moderate episode of major depressive disorder without prior episode (HCC) Flank pain Frequent falls HLD (hyperlipidemia) HTN (hypertension) Hyponatremia Hypothyroidism Leukocytosis Impaired cognition LPRD (laryngopharyngeal reflux disease) Olecranon bursitis of right elbow Osteopenia Pericardial effusion Pyelonephritis Wernicke's encephalopathy COVID-19
- Andere Medikamente
- acetaminophen (TYLENOL) 325 MG tablet amLODIPine (NORVASC) 5 MG tablet atorvastatin (LIPITOR) 20 MG tablet bisacodyl (DULCOLAX) 10 MG suppository bisacodyl 5 MG enteric coated tablet folic acid (FOLVITE) 1 MG tablet levothyroxine (SYNTHROID
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 24.08.2022
- Impfdatum
- 20.12.2021
- Beginn
- 16.08.2022
- Tage bis Beginn
- 239,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram pulmonary abnormal
Asthenia
Biopsy lung
Biopsy lymph gland
Blood creatinine increased
Blood potassium decreased
Blood sodium decreased
Bronchoscopy abnormal
COVID-19
Cough
Culture positive
Dyspnoea
Hypoxia
Increased bronchial secretion
Lung consolidation
Lymphadenopathy
Mediastinal disorder
Pathology test
Symptomtext
Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 8/16/2022 Discharge Date: 8/20/2022 HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness. He called EMS, and was placed on 4 L of oxygen due to hypoxia. Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6. CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe. He was noted to have lymphoid tissue in the mediastinum and hilum. He was tested for COVID-19, which returned positive. He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department. He was admitted to the hospitalist service for further management. Upon admission, he was continued on Decadron for this COVID-19. SLP was consulted, given his known history of dysphagia and aspiration. The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way. SLP did not feel that further evaluation was necessary, given this history. Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted. Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease. Therefore, ID was also consulted. They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis. Pulmonology felt that bronchoscopy should be done, and was completed on 8/18. Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy. Pathology is pending. Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge. He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air. He was felt stable for discharge on 8/20/22. He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia. He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations. He should follow-up with Pulmonology in 1 month. He should follow-up with his PCP in 1 week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic kidney disease (CKD), stage IV (severe) Drug-induced peripheral neuropathy Carcinoma of oropharynx HTN (hypertension) Anemia Arthropathy of shoulder region Osteoradionecrosis of mandible Effects of radiation, unspecified Hypothyroidism, unspecified type Coronary artery disease Hypothyroidism due to Hashimoto's thyroiditis S/P CABG x 2 Peripheral neuropathy, secondary to drugs or chemicals Hypertensive urgency Dysphagia Immunization counseling Unspecified severe protein-calorie malnutrition Bronchiectasis without complication Dizziness Bilateral carotid artery stenosis Neurogenic orthostatic hypotension Hospital-acquired pneumonia Benign esophageal stricture Leukocytosis Hypoxemia Chronic Pulmonary aspergillosis, complicated by frequent aspiration events and bacterial pneumonia Weakness generalized Aspiration pneumonia Abnormal CT scan, lung Klebsiella pneumonia History of CVA (cerebrovascular accident) Cardiac arrest Adrenal insufficiency Symptomatic carotid artery stenosis without infarction, right Stage III pressure ulcer of sacral region Familial dysautonomia (riley-day) CVA, old, hemiparesis Convulsions, unspecified convulsion type Pneumonia due to COVID-19 virus Lung infiltrate on CT Mediastinal adenopathy Lymphadenopathy
- Andere Medikamente
- albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 80 MG tablet clopidogrel (PLAVIX) 75 MG tablet
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 16.12.2021
- Beginn
- 22.07.2022
- Tage bis Beginn
- 218,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Appetite disorder
Cough
Dyspnoea
Fatigue
Nausea
Symptomtext
appetite change, fatigue, cough, SOB, nausea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 30.12.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Cardiac stress test
Catheterisation cardiac abnormal
Chest X-ray
Chest pain
Coronary artery occlusion
Echocardiogram abnormal
Electrocardiogram
Influenza like illness
Ultrasound Doppler
Symptomtext
She did experience flu like symptoms after the vaccine. Then, approximately one month after the vaccine she started experiencing chest pain. Then it progressed more and more chest pains. On 6/18/2022, she went to the ER. While at ER she had EKG, blood work, chest x-ray, stress test, and electrocardiogram. The echocardiogram notated something. Then on 6/28/2022, she had a heart cath performed. There was a minor blockage that shouldn't cause the chest pain. The doctor was not for sure why she is having these issues.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- EKG; Blood work; Chest x-ray; Stress test; Electrocardiogram; Heart Cath; Vascular Ultrasound
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN; Diabetes; Arthritis; Rotator cuff tears
- Andere Medikamente
- None
- Allergien
- Sulfa; Latex; Iodine Contrast; Cipro; Macrobid; Atorvastatin; Adhesive Tape
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 05.07.2022
- Impfdatum
- 30.12.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Aortic dilatation
Cardiac stress test
Chest pain
Electrocardiogram normal
Influenza like illness
Symptomtext
After the vaccine, he did experience the normal flu like symptoms. Then, he started experiencing chest pains in January. It was a poking chest pain in the middle. He has never had to take aspirin for chest pain but does now. He was complaining of chest pains more often. He went to a cardiologist and did a stress test, EKG, and an electrocardiogram which was normal. He was told that his aortic arch is dilated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Stress test - normal; EKG - normal; Electrocardiogram - normal
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Back issues; HTN; Diabetes; Arthritis
- Andere Medikamente
- Normal daily medications
- Allergien
- Penicillin; Cortisone; Iodine Contrast
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 20.06.2022
- Impfdatum
- 17.11.2021
- Beginn
- 15.06.2022
- Tage bis Beginn
- 210,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Atrial fibrillation
Blood magnesium normal
Blood potassium normal
Brain natriuretic peptide increased
COVID-19
Cardiac pacemaker insertion
Chest pain
Fatigue
Nausea
Pneumonia
Troponin normal
Vomiting
White blood cell count increased
Symptomtext
2 weeks ago she was diagnosed with covid. She was started on medication but had n/v and could not keep her medication down. She was then diagnosed with pneumonia and started on azithromycin. She started to have chest pain over the last couple of days. She presented to the ER today and was found to be in a-fib with rates in the 140s. She states she has been very fatigued lately. Her PPM was interrogated and she has been in a-fib for about 50% of the time. She continues on eliquis and has not missed any doses. Her ER workup was positive for elevated WBC, BNP of 5659, potassium and magnesium WNL, troponins flat. She was started on a diltiazem drip. She will be admitted to cardiology for further treatment. Currently in the hospital (not in ICU on 06/20/2022).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.03.2021
- Beginn
- 14.05.2022
- Tage bis Beginn
- 439,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Angiogram pulmonary abnormal
Asthenia
Dyspnoea
Fatigue
Hypoxia
Laboratory test abnormal
Loss of personal independence in daily activities
Lung opacity
Symptomtext
This is a 62 yo male who presented to the ED with c/o of worsening SOB. He has a PMHx as listed including an atypical PNA a couple years ago w/u by clinic per patient no clear explanation regarding condition a couple of years ago. Since then he has been fairly stable, follows with doctor as an OP. He was seen as OP 5/13 d/t progressive SOB, extreme fatigue over the last several weeks. Additionally, he admits to generalized weakness, unable to do activities he was previously able to perform without breaks. He denies any nausea, vomiting, diarrhea, constipation, fever, recent illness, medication changes, sick family members, chest pain, heart palpitations, peripheral edema, bird/bat exposures, TB hx/exp He had a CTA chest 5/13 which was negative for pulmonary embolism but has evidence of diffuse bilateral ground glass opacities with some nodular infiltrates. He was sent home on home oxygen 2LNC to wear continuously and told to come to the ER for persistent hypoxia or worsening symptoms. Today he comes to the ER with worsening hypoxia, SpO2 74% on RA, placed on 6L for SpO2 91%. Lab work fairly unremarkable. Pulmonology consulted in the ER, recommended admission for further work up. He was placed on Augmentin and doxycycline. Will be NPO after midnight for possible BAL in the AM. Hospital medicine asked for admission. . PT IS INPATIENT AT THIS TIME.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 02.05.2022
- Impfdatum
- 17.12.2021
- Beginn
- 26.12.2021
- Tage bis Beginn
- 9,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Arthralgia
Brain stem auditory evoked response
Hypoaesthesia
Immunoglobulin therapy
Inflammation
Joint swelling
Laboratory test
Lumbar puncture
Magnetic resonance imaging spinal
Myelitis transverse
Pain
Pain in extremity
Paraesthesia
Spinal disorder
Visual evoked potentials
Symptomtext
Swelling of ankles and ankle pain one week after 3rd dose(booster). Treated with 6 days of steroid by primary care doctor. Symptoms resumed after steroid with additional pain throughout the trunk and legs. Referred to Rheumatologist. 12 days steroid and pain resolved and resumed after steroids. Numbness pain and tingling began in late February. Additional steroid resolved pain. Numbness and tingling continued. Rheumatology referred to emergency room and neurology. MRI of spine and spinal tap showed spinal inflammation and lesions. Hospital admission for 10 days. Received ivig and high dose steroid. Diagnosis is transverse myelitis. Continued treatment with steroids, baclofen and pegabalin. Numbness and tingling continues. Physical therapy prescribed. Symptoms remain as of current date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- 10,0
- Labordaten
- 3/24 Spinal MRI, 3/25lumbar spinal puncture, brainst auditory evoked potential, visual evoked potential. Multiple labs ongoing.
- Aktuelle Erkrankungen
- Hypertension
- Vorgeschichte
- None
- Andere Medikamente
- Telmasartan 20mg
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 25.04.2022
- Impfdatum
- 21.12.2021
- Beginn
- 21.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Blood test normal
Condition aggravated
Herpes virus infection
Lymph node pain
Lymphadenopathy
Pain
Peripheral swelling
Swelling
Ultrasound scan normal
Symptomtext
I got the vaccine and then that day I noticed that the lymph node under my left arm pit was swollen. I found online that that was normal for a week or so but at around mid February, when it was still swollen, I began to worry. I then had a herpes outbreak which tends to only occur when my immune system is struggling with something else. I then went to the doctor who tested for cancer with blood work and an ultra sound as the lymph node had become painful as well as swollen. They did not find anything but after a few more weeks, I was still experiencing pain so I went back to the doctor who wasn't sure of what could be causing the issues. I basically always have a bit of pain and swelling in that area and the pain will sometimes radiate out to my chest and arm. After 5 months I am still experiencing this pain and swelling with no answer as to what is causing it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- Blood Work-nothing found February 2022; Ultra Sound- nothing found February 2022.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- GERD; IBS; Herpes; interstitial cystitis
- Andere Medikamente
- None.
- Allergien
- Amoxycillin; sulfa; codeine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 12.04.2021
- Beginn
- 26.08.2021
- Tage bis Beginn
- 136,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Aphasia
COVID-19
Dyspnoea
Exposure to SARS-CoV-2
Malaise
SARS-CoV-2 test positive
Symptomtext
8/26/21 presents to urgent care requesting COVID-19 testing due to experiencing COVID-19 symptoms and exposure to COVID-19 8/27/21 PMH of CAD s/p PCI, HTN, Hyperlipidemia, COPD, Tobacco Abuse, Obesity and RA who presented to ER with c/o SOB and difficulty with speech
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 8/26/21 SARS-CoV-2 (COVID-19) by PCR, Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 21.02.2022
- Impfdatum
- 10.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 14,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Heart rate decreased
Heart rate irregular
Hypertension
Symptomtext
High blood pressure, low pulse, irregular heartbeat.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- Blood work.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Thyroid
- Andere Medikamente
- Benazepril; alopurinol; Tirosint; Xanax
- Allergien
- Cipro
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 29.12.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Decreased appetite
Diarrhoea
Disturbance in attention
Facial pain
Fatigue
Headache
Injection site pain
Paraesthesia
Tension headache
Gallbladder disorder
Head discomfort
Vomiting
Symptomtext
gallbladder and abdominal issues / abdominal problem; decrease in appetite; diarrhea; vomiting; sheer exhaustion; Throbbing on her face and back of her head; Throbbing on her face and back of her head; could not concentrate; discomfort on the side and back of the head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 29Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, doctor mentioned it might be a possible TIA (ministroke) or a complex migraine), administration date: 30Jan2021, for Covid-19 Immunization, reaction(s): "right side of the face and head she had a tingling feeling that travelled down"; Bnt162b2 (Dose 2, single), administration date: 2021, for Covid-19 Immunization, reaction(s): "sheer exhaustion". The following information was reported: FATIGUE (non-serious) with onset Jan2022, outcome "unknown", described as "sheer exhaustion"; HEADACHE (non-serious), FACIAL PAIN (non-serious) all with onset Jan2022, outcome "not recovered" and all described as "Throbbing on her face and back of her head"; DISTURBANCE IN ATTENTION (non-serious) with onset Jan2022, outcome "unknown", described as "could not concentrate"; HEAD DISCOMFORT (non-serious) with onset Jan2022, outcome "not recovered", described as "discomfort on the side and back of the head"; GALLBLADDER DISORDER (non-serious), outcome "unknown", described as "gallbladder and abdominal issues / abdominal problem"; DECREASED APPETITE (non-serious), outcome "unknown", described as "decrease in appetite"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; VOMITING (non-serious), outcome "unknown", described as "vomiting". Therapeutic measures were taken as a result of fatigue, headache, facial pain, head discomfort. Additional Information: The patient felt all those side effects again after receiving the booster dose on 29Dec2021. Within 3-4 days after booster, she had sheer exhaustion that was unbelievable, and it was 20Jan2022 now and she still felt the throbbing on her face and back of her head. She was scheduled for EEG of her Head to see what was wrong. With all the side affects her job was suffering, she could not concentrate for months, and these side effects never went away, there was always a discomfort on the side and back of the head. She took tylenol for it, but she wanted to stop that as she did not want to affect her Liver. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 06.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 7,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anxiety
Asthenia
Blood test
Fatigue
Hypertension
Inflammation
Platelet count increased
Tachycardia
Symptomtext
Tachycardia, high blood pressure, anxiety, pulmonary inflammation, sensation of generalized inflammation, generalized weakness, chronic fatigue. I was in the emergency room, and they did a blood test and the doctor told me that I had an increase in platelets, caused by inflammation. And that's how I feel. The doctor in the emergency room prescribed me Ibuprofen and albuterol, and recommended that I ask a family doctor to continue investigating this. The doctor in the emergency room prescribed me Ibuprofen and albuterol, and recommended that I ask a family doctor to continue investigating this.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- I was in the emergency room, and they did a blood test and the doctor told me that I had an increase in platelets, caused by inflammation. And that's how I feel.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 31.12.2021
- Beginn
- 03.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Dehydration
Fatigue
Headache
Oropharyngeal pain
Vomiting
Symptomtext
Patient stated on 1/3/2022 in the evening, she got a bad headache. She had some relief with ibuprofen, but she was dehydrated, had chills, tired, vomiting and sore throat. Symptoms mostly resolved by 1/4/2022 at 5:10 pm. She reported she was able to drink fluids and keep them down.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 02.01.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Dyspnoea
Injection site erythema
Injection site swelling
Physical examination
Urticaria
Symptomtext
Chest tightness red swelling at injection site shortness of breath hives covering entire torso and upper legs and both arms. Was prescribed Deltasone and Atarax told to use inhaler already prescribed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Physical examination by physician
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Anaphylaxis to cinnamon
- Andere Medikamente
- Allegra, Serc, montelukast, vitamin B complex, vitamin C
- Allergien
- Demerol, cinnamon
- Vorherige Impfungen
- -
- Staat
- VI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 01.01.2022
- Impfdatum
- 17.12.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ophthalmic migraine
Visual impairment
Symptomtext
Ocular Migrane - distortion of partial field of vision in both eyes, just to left of center of field of view; distortion similar to what is seen on a digital television when the signal is degraded. Most of the rest of the field of view appeared to be normal. Condition last for up to 30 minutes. Has repeated on occasion since, most recent, today 1/1/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ophthalmic migraine
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- benign prostatic hyperplasia
- Andere Medikamente
- 500 mg Magnesium, Multivitamin, 1200 mg Omega 3
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 20.12.2021
- Impfdatum
- 17.12.2021
- Beginn
- 17.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Skin warm
Tremor
Symptomtext
Patient shaking uncontrollably about 20 minutes after administration of the vaccine. Continuously warm-to-touch and but shaking involuntarily. She spoke to me but could not stop shaking. I recommended a 911 call. They took her to the hospital for observation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyspnoea
Heart rate decreased
Hyperhidrosis
Peripheral coldness
Visual impairment
Symptomtext
Profuse sweating, diaphoretic, heart rate dropped to 50, vision turned black, shortness of breath. Skin cold to touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 30.11.2021
- Impfdatum
- 26.10.2021
- Beginn
- 31.10.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Ataxia
Balance disorder
COVID-19
Computerised tomogram head normal
Decreased appetite
Immunoglobulin therapy
Liver function test normal
Magnetic resonance imaging head normal
Malaise
Myoclonus
SARS-CoV-2 test positive
Tremor
Symptomtext
10/27/21: Patient felt weaker 10/31/21: Started experiencing balance issues and became more weak 11/12/21: Admitted to hospital with anorexia, ataxia, feeling ill and tremors 11/15/21: Consulted neurology due to persistent shakiness with sitting and standing; neurology recommended Solumedrol 1 gram IV daily x 3 days 11/17/21: Saw improvement with Solu-medrol 11/18/21: Neurology recommended IVIG 0.4mg/kg IV daily x 5 days (for possible etiology) and Depakote 15 mg/kg IV x 1 dose, then 500 mg po BID (for myoclonus). 11/22/21: Patient finished treatment. Tremors were less intense. Transferred to acute rehab facility for further therapies.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- 10,0
- Labordaten
- 11/06/21: Positive COVID test 11/12/21: Head CT non contrast--negative; LFTs are normal 11/15/21: Second COVID test is negative 11/16/21: MRI of brain-negative
- Aktuelle Erkrankungen
- Possible COVID (tested positive 11/06/21)
- Vorgeschichte
- ? Hyperlipidemia ? Hypertension ? Hypothyroidism ? Stage III CKD
- Andere Medikamente
- ? Aleve take 1 tablet PRN ? Artificial tears ? Levothyroxine 75 mcg once daily ? Lisinopril 20 mg once daily ? Ocuvite 1 tablet daily
- Allergien
- Amoxicillin-Rash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 26.11.2021
- Impfdatum
- 30.09.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Chest pain
Chills
Diarrhoea
Fatigue
Lymphadenopathy
Migraine
Myalgia
Nausea
Pain
Palpitations
Pyrexia
Vomiting
Symptomtext
11pm Migraine lasted 10 days 2am chest pain, palpitations, throbbing lasted 24h 3am pain in wrists and elbows lasted 2 days 7am muscle pain lasted 4 days 7am fatigue lasted 10 days 7am nausea, diarrhea throwing up lasted 2 days 12 pm swollen gland in neck under arms ant groin lasted 24 hours 5pm fever chills lasted 24 hours
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Kidney stones
- Andere Medikamente
- Vyvanse
- Allergien
- No
- Vorherige Impfungen
- Influenza vaccine in 2012
- Staat
- GA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 20.11.2021
- Impfdatum
- 31.10.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Condition aggravated
Depression
Fatigue
Headache
Memory impairment
Neck pain
Nightmare
Sciatica
Symptomtext
Sciatica and neck pain on right side. Headaches. Fatigue. Memory issues. Anxiety and Depression flareup. Nightmares. This has lasted for three weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High blood pressure. GERD. depression.
- Andere Medikamente
- Effexor. Lamictal. Protonix. Pepcid. Metoprolol. Flecainide. Tiadylt.
- Allergien
- Demerol
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 06.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Insomnia
Restless legs syndrome
Symptomtext
The restless feeling in my legs got worse. It started early in the evening before I went to bed, which usually does not happen. It would prevent me from sleeping because I still had the feeling, so I would have to get up at night and walk around. I went to the doctor on 09/08/2021 and he increased my dose of ropinirole, and it seems like the symptoms are much better now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma Low Thyroid GERD High Cholesterol Restless Leg Syndrome Periodic Limb Movement Disorder
- Andere Medikamente
- Levothyroxine Liothyronine Pantoprazole Vitamin D Vitamin B Ropinirole Crestor Zyrtec Pulmicort Inhaler
- Allergien
- CAT Scan Dye Penicillin Trees Dogs Cats Grass Mold
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 10.11.2021
- Impfdatum
- 25.10.2021
- Beginn
- 03.11.2021
- Tage bis Beginn
- 9,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Electrocardiogram abnormal
Symptomtext
Chest pain, abnormal EKG. Vaccine was given at local Pharmacy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- EKG 11.10.2021
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Depression, fibromyalgia, high cholesterol, osteoporosis
- Andere Medikamente
- Alendronate, probiotic, calcium with vitamin d, Benadryl, escitalopram, multi vitamin, eye vitamin, rosuvastatin, tramadol, co q 10
- Allergien
- Lipitor - hives
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 01.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Dyspnoea
Heart rate increased
Hot flush
Myalgia
Pyrexia
Symptomtext
Muscle soreness Fever (101?) Hot flashes Shortness of breath Increased heart rate Dizziness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic back/shoulder pain.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 25.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 23.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest discomfort
Chest pain
Symptomtext
Patient reports chest discomfort/minor pain starting approximately 2 days following injection. Sitting made the discomfort worse, standing helped to alleviate it. Heart rate did not seem off, but location of pain/discomfort was near heart. Pain/discomfort lasted into the next day following an evening of rest. 400 mg of Ibuprofen administered ~18 hrs after initial onset helped to lessen symptoms. Additional 400 mg of Ibuprofen and 10mg Loratadine was taken a ~4 hours later. Symptoms did not return the following morning.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Aleve, Vitamin C, Vitamin D, Zinc, L-Lysine, L-Arginine, low dose aspirin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 23.10.2021
- Impfdatum
- 13.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain upper
Arthralgia
Blood test
Chest pain
Discomfort
Eye pain
Flank pain
Headache
Nausea
Tenderness
Urine analysis
Vision blurred
Vomiting
Symptomtext
Symptoms varied over the course of 10+ days. - Day 1-2: Piercing headache and pain behind eyes that resulted in blurry vision for 20 minutes. Pains in chest when inhaling deeply. Pain and pressure behind knees. Nausea. Persistent pain in flanks. - Day 3-7: Sever pain in stomach particularly immediately after eating. Nausea, vomiting. Persistent pain in flanks. - Day 7-10: Pain in flanks, stomach pain, headaches and tenderness in left upper thigh - Symptoms continue
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Blood test/Urinalysis
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 19.10.2021
- Impfdatum
- 19.10.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest pain
Dyspnoea
Electrocardiogram
Full blood count
Heart rate increased
Metabolic function test
Troponin I
Urticaria
Symptomtext
Chest pain, trouble breathing, elevated heart rate, hives Transported to hospital, EKG and blood work given methylpresnisone, oxycodone, famotidine, lorazepam, hydromorphone
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- CBC W/ diff Comprehensive Metobolic Panel High Sensitivity Troponin T All conducted 10/19/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Lupus, Autoimmune-hepatitis, chronic pain, anxiety, ADHD
- Andere Medikamente
- Oxycodone, Adderall, gabapentin, hydroxychloroquine, prednisone, valtrex, Xanax
- Allergien
- Latex, TDAP, Sulfa, Trimethoprim, Tylenol, Benadryl, tramadol, Neproxen
- Vorherige Impfungen
- Anthrax Age 20 (2008),TDAP age 31 (April 2020) Both reactions resulted in swollen lymph nodes trouble breathing, hives
- Staat
- VT
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 13.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 09.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Breast swelling
Discomfort
Dyspnoea
Injection site pain
Injection site swelling
Oedema peripheral
Peripheral swelling
Symptomtext
Site pain and swelling, under arm swelling and soreness that began the day after the vaccine. Swelling increased over next four days to the point of fluid build up in L arm, L breast, L back, L shoulder causing shortness of breath and discomfort. I followed up with my PCP due to the shortness of breath and continued swelling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- asthma (not problematic for years)
- Andere Medikamente
- Women's multi vit, immune booster vit, flownase
- Allergien
- yellow jackets, wasps, regland
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 12.09.2021
- Beginn
- 12.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Electrocardiogram
Headache
Heart rate increased
Symptomtext
Difficulties breathing, rapid heart beat, headache
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- ECG
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- No
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 17.10.2022
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling hot
Visual impairment
Symptomtext
Employee became lightheaded and felt 'hot.' Indicated he had some vision changes but those dissipated shortly after occurrence. Was instructed to call his PCP to discuss options for possible treatment. Employee went back to work after a few minutes and hydration, and indicated he felt much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Product storage error
Pyrexia
Vaccine positive rechallenge
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD CHILLS AND A FEVER WILL ALL COVID VACCINES HE RECEIVED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 03.11.2021
- Beginn
- 23.01.2022
- Tage bis Beginn
- 81,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Back pain
Blood pressure increased
COVID-19
Colostomy
Haemoglobin decreased
Pyrexia
SARS-CoV-2 test positive
Symptomtext
COVID+ 1/23. Pt presents to ED 2/8 with low hemoglobin and fever. Pt does not appear to be in any respiratory distress. 2/10 no acute issues overnight. Denies chest pain, shortness of breath, abd pain, no fever or chills and c/o back pain. COVID test negative upon arrival. Patient is a&o x3.vital signs are stable. Patient continued to be on IV antibiotics, s/p cath and colostomy intact, PEG tube in place. 2/13 pt medicated for elevated blood pressure with losartan and norvasc as ordered. 2/14 pt still very elevated BP, order to give hydralazine. Pt discharged to residential facility 2/16.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- 9,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- AMS (altered mental status) AMS (altered mental status) Obesity (BMI 30-39.9) Sacral pressure ulcer Chronic paraplegia (CMS/HCC) Chronic suprapubic catheter (CMS/HCC) Neurogenic bladder S/P percutaneous endoscopic gastrostomy (PEG) tube placement (CMS/HCC)
- Andere Medikamente
- amLODIPine (NORVASC) 5 MG PO Tab amLODIPine (NORVASC) 5 MG PO Tab ammonium lactate (LAC-HYDRIN) 12 % EXTERNAL Lotion apixaban (ELIQUIS) 5 MG PO Tab Ascorbic Acid 500 MG PO Tab atorvastatin (LIPITOR) 80 MG PO Tab buprenorphine-naloxone 4-1
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 07.05.2022
- Impfdatum
- 21.03.2021
- Beginn
- 22.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- UN / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adnexa uteri pain
Biopsy soft tissue
Dysmenorrhoea
Postmenopausal haemorrhage
Ultrasound scan normal
Symptomtext
The following day, day 2 of vaccination. I started experiencing sharp stabbing pain in my ovaries. The pain was like I never felt before, so sharp that it would make me jump and scream due to the fast and sharp pain. On day 4, the sharp pain continued and menstrual cramps started (both pains are very different). On this day at night, I started bleeding like a regular menstrual period ( which I have not had in +4yrs due to menopause). The bleeding, cramps and sharp pain continued for 3 weeks. Then 2nd dose was on 4/20 which caused same cycle but not as sharp the pain and less cramps and bleeding. AND NOW I constantly (weekly) get cramps and sharp pain with sporadic blood spotting.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Adnexa uteri pain
- Hospital-Tage
- -
- Labordaten
- GYN did a biopsy, ultrasounds and found nothing.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 02.05.2022
- Impfdatum
- 14.12.2021
- Beginn
- 11.04.2022
- Tage bis Beginn
- 118,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ageusia
Body temperature increased
Cough
Decreased appetite
Disturbance in attention
Fatigue
Headache
Influenza like illness
Oropharyngeal pain
SARS-CoV-2 test positive
Throat irritation
Symptomtext
I was fully vaccinated and on 4-11-22, I started having a scratchy/sore throat, cough, intense headache and my temperature spiked to 100.9, I felt fatigued and I could not concentrate. I had a poor appetite. I lost sense of taste for a short while. I felt like I could compare it to the flu. I had 3 home tests for COVID-19. The first was negative and the next two were positive on 4-14-22. I began feeling better by 4-16-22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Home COVID-19 tests x3 on 4-14-22. 2 were positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Ibuprofen 200mg 2 tabs as needed, Chondroitin with MSM 1000mg twice daily, Fish Oil 1000mg 2 tabs daily, Acyclovir 400mg as needed up to 3 times daily for 4-5 days (2 times yearly)
- Allergien
- Bee Venom
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 30.03.2022
- Impfdatum
- 11.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
SARS-CoV-2 test
Vaccination failure
Dry skin
Inflammation
Rash pruritic
Skin exfoliation
Urticaria
Symptomtext
Severe hives; rash itching; inflammation; dry peeling skin located on my face eyes lips neck and the outside of both hands; dry peeling skin located on my face eyes lips neck and the outside of both hands; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 04:00 (Lot number: FD0810) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Acid reflux" (unspecified if ongoing); "if covid prior vaccination: Yes" (unspecified if ongoing). Concomitant medication(s) included: PRILOSEC [OMEPRAZOLE MAGNESIUM]. Past drug history included: Tetracycline, reaction(s): "Known allergies: Tetracycline/ erythromycin"; Erythromycin, reaction(s): "Known allergies: Tetracycline/ erythromycin". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6203, Location of injection: Arm Left, Vaccine Administration Time: 03:00 PM), administration date: 08Mar2021, when the patient was 66 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 15Feb2021, when the patient was 66 years old, for COVID-19 immunization. The following information was reported: URTICARIA (life threatening) with onset 14Oct2021, outcome "not recovered", described as "Severe hives"; RASH PRURITIC (life threatening) with onset 14Oct2021, outcome "not recovered", described as "rash itching"; INFLAMMATION (life threatening) with onset 14Oct2021, outcome "not recovered", described as "inflammation"; DRY SKIN (life threatening), SKIN EXFOLIATION (life threatening) all with onset 14Oct2021, outcome "not recovered" and all described as "dry peeling skin located on my face eyes lips neck and the outside of both hands". The events "severe hives", "rash itching", "inflammation", "dry peeling skin located on my face eyes lips neck and the outside of both hands" and "dry peeling skin located on my face eyes lips neck and the outside of both hands" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Nov2021) positive. Therapeutic measures were taken as a result of urticaria, rash pruritic, inflammation, dry skin, skin exfoliation. Clinical course: 4 rounds Steroids / Pepcid Zyrtec Allegra etc. event included Severe hives rash itching inflammation dry peeling skin located on my face eyes lips neck and the outside of both hands. No follow-up attempts are possible. No further information is expected. Follow-up (25Mar2022): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200463650 Same reporter/SD, Different potential/AE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash pruritic
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211127; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Acid reflux (esophageal); COVID-19
- Andere Medikamente
- PRILOSEC [OMEPRAZOLE MAGNESIUM]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 15.03.2022
- Impfdatum
- 03.11.2021
- Beginn
- 03.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Fatigue
Feeling abnormal
Headache
Nasal congestion
Pain
Pain in extremity
Symptomtext
body aches; nasal congestion; dazedness; chills; headache; arm pain; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 31 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm right, administration date 03Nov2021 18:15 (Lot number: FD0810) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "GERD" (unspecified if ongoing). Concomitant medication(s) included: FLU, administration date 14Oct2021; PANTOPRAZOLE; CARAFATE; MILK THISTLE; D3; B12-VITAMIIN. Past drug history included: Tetracycline, reaction(s): "allergies". Vaccination history included: Bnt162b2 (Dose 1, Batch/Lot No: EW0169, Location of injection: Arm Right), administration date: 16Apr2021, when the patient was 31 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Batch/Lot No: EW0183, Location of injection: Arm Right, Vaccine Administration Time: 10:15 AM), administration date: 08May2021, when the patient was 31 years old, for COVID-19 Immunization. The following information was reported: PAIN (non-serious) with onset 03Nov2021, outcome "recovering", described as "body aches"; NASAL CONGESTION (non-serious) with onset 03Nov2021, outcome "recovering", described as "nasal congestion"; FEELING ABNORMAL (non-serious) with onset 03Nov2021, outcome "recovering", described as "dazedness"; CHILLS (non-serious) with onset 03Nov2021, outcome "recovering", described as "chills"; HEADACHE (non-serious) with onset 03Nov2021, outcome "recovering", described as "headache"; PAIN IN EXTREMITY (non-serious) with onset 03Nov2021, outcome "recovering", described as "arm pain"; FATIGUE (non-serious) with onset 03Nov2021, outcome "recovering", described as "fatigue". Therapeutic measures were not taken as a result of pain, nasal congestion, feeling abnormal, chills, headache, pain in extremity, fatigue. Additional information: The patient did receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: GERD
- Andere Medikamente
- PANTOPRAZOLE; CARAFATE; MILK THISTLE; D3; B12-VITAMIIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 27.12.2021
- Beginn
- 03.01.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Pain
Rash
Symptomtext
01/03/2022 pain started and by 01/06/2022 I broken out in shingles. I'm still feeling the after effects of the shingles. On 01/10/2022 I was diagnosed with it by PCP. The days I was hurting before shingles broke out, a rash had showed up in the spots I was hurting.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Sleep apnea, type 2 diabetes
- Andere Medikamente
- Calcium with vitamin D, Zinc, Cinnamon, Fish oil, multivitamin, vitamin C, small dose aspirin, coquet, atorvastatin, amlodipine, omeprazole.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 17.02.2022
- Impfdatum
- 15.10.2021
- Beginn
- 16.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Chills
Dizziness
Headache
Nausea
Pyrexia
Symptomtext
headache; nausea; fever; joint pain; dizziness; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 68 year-old male patient received bnt162b2 (COMIRNATY), administered in arm right, administration date 15Oct2021 16:00 (Lot number: FD0810) at the age of 68 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "quadruple bypass", start date: 2008 (unspecified if ongoing); "Heart Disease" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: TOPROL (ongoing); CRESTOR taken for blood cholesterol (ongoing); ASPIRIN [ACETYLSALICYLIC ACID]. Vaccination history included: Bnt162b2 (1st Dose, LOT: EL3246), administration date: 18Jan2021, when the patient was 68 years old, for COVID-19 Immunization; Bnt162b2 (2nd dose, LOT: EM9810), administration date: 08Feb2021, when the patient was 68 years old, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 16Oct2021, outcome "not recovered", described as "headache"; NAUSEA (non-serious) with onset 16Oct2021, outcome "unknown", described as "nausea"; PYREXIA (non-serious) with onset 16Oct2021, outcome "unknown", described as "fever"; ARTHRALGIA (non-serious) with onset 16Oct2021, outcome "unknown", described as "joint pain"; DIZZINESS (non-serious) with onset 16Oct2021, outcome "unknown", described as "dizziness"; CHILLS (non-serious) with onset 16Oct2021, outcome "unknown", described as "chills". Therapeutic measures were taken as a result of headache, nausea, pyrexia, arthralgia, dizziness, chills. Additional information: He got the booster about 4:00pm on Friday. About 2:00am he started to exhibit symptoms of headache, nausea, fever, joint pain, dizziness and severe chills. Clarified that by Friday, the caller was referring to Friday, 15Oct2021 and that the symptoms started 2:00am, 16Oct2021. He was not experiencing these symptoms right now except that he has a slight headache. He was in bed all day Saturday and half of the day Sunday. Sunday afternoon, it slowly started to subside. Treatment: He took one Tylenol on Saturday afternoon and that was it. Caller states that with the second dose, it was all of the same symptoms, the headache, nausea, fever, joint pain, dizziness and severe chills. The onset was a little sooner after getting the vaccine. It was probably a little more in severity. That time, it lasted the same amount of time, about 48 to 72 hours. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Bypass surgery; Cholesterol; Heart disease, unspecified
- Andere Medikamente
- TOPROL; CRESTOR; ASPIRIN [ACETYLSALICYLIC ACID]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 02.02.2022
- Impfdatum
- 29.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Lymphadenopathy
Symptomtext
Patient called today (2/2/22) to state that she has very swollen lymph nodes in her right arm after getting her vaccine on 1/29/22. She states that she experienced a very sore armpit in her right arm the evening of the 29th and then the next morning experienced "a lot" of swelling in her lymph nodes. She states that the swelling is still present today and has not gone down since then.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 26.01.2022
- Impfdatum
- 27.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Illness
Malaise
Pain
Symptomtext
General soreness and illness the next day. From that day until January 24th, 2022, I was generally ill feeling, tired and didn't feel like I was at 100%. More like a malaise making me feel like I was at 70% wellness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Stress-induced asthma
- Andere Medikamente
- Montelukast, Breo Ellipta, Al butylerol
- Allergien
- Cipro, Year round environmental allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dizziness
Symptomtext
Shortly after the administration of both vaccines patient started to get lightheaded. She stated that she sometimes gets like this after vaccines. She laid down on the floor, drank some water and was able to eat some fruit snacks. Her symptoms resolved in 15 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 04.03.2021
- Beginn
- 21.01.2022
- Tage bis Beginn
- 323,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Arthralgia
Body temperature increased
COVID-19
Dizziness
Fall
Femoral neck fracture
Haemoglobin decreased
Head injury
Joint injury
Pancytopenia
Platelet count decreased
Rib fracture
SARS-CoV-2 test positive
White blood cell count decreased
X-ray abnormal
Symptomtext
Patient is a 56 yr old male with medical history significant for cirrhosis with history of hep B and hep C which he states have both been treated and cleared, chronic back pain on daily opioids, CAD with stents, DM2, and depression/anxiety on daily diazepam. He reports that he had been feeling dizzy all day today, and when he stood up from the toilet, he again became dizzy and fell, landing on his R hip. He also reports that he hit his R forehead, but has no bruising or pain there, no headache. He is unsure why he was dizzy today, but states it may be due to his oxycodone and diazepam, although he takes these every day without dizziness. Due to severe R hip pain, EMS was called and he was brought in to ED for further evaluation. In the ED, Xrays reveal mildly displaced R femoral neck fracture and L lateral 9th rib fracture without displacement or pneumothorax. He is pancytopenic with WBC 1.7, hgb 11.6, and plt 39. He has a temp of 99.4 and COVID test was positive. He is fully vaccinated and boosted, booster was given in October 2021. He denies SOB, denies cough, denies any COVID symptoms. Recorded O2 saturations noted to be variable from 97% on room air to 89% on 2L per cannula. Dr has been consulted and hip repair is planned for tomorrow. He has received dilaudid and zofran in the ED, and the hospitalist service is asked for admission. PT IS INPATIENT AT THIS TIME.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 288249
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 22.01.2022
- Impfdatum
- 20.11.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Immunisation
Oropharyngeal pain
SARS-CoV-2 test
Vaccination failure
Symptomtext
Positive PCR test for COVID-19.; sore throat; Positive PCR test for COVID-19.; dose 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 20Nov2021 (Lot number: FD0810) at the age of 46 years as dose 3 (booster), single, intramuscular, administered in arm left, administration date 05Apr2021 (Lot number: ER8735) as dose 2, single and intramuscular, administered in arm left, administration date 14Mar2021 (Lot number: EN6208) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. The following information was reported: IMMUNISATION (medically significant) with onset 20Nov2021, outcome "unknown", described as "dose 3"; COVID-19 (medically significant) with onset 06Jan2022, outcome "recovering", VACCINATION FAILURE (medically significant), outcome "unknown" and all described as "Positive PCR test for COVID-19."; OROPHARYNGEAL PAIN (non-serious) with onset 06Jan2022, outcome "recovering", described as "sore throat". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (01Jan2022) negative, notes: Nasal Swab; (05Jan2022) negative, notes: Nasal Swab; (07Jan2022) negative, notes: Nasal Swab; (08Jan2022) positive, notes: Nasal Swab; (08Jan2022) negative, notes: Nasal Swab; (09Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19, oropharyngeal pain. Clinical course: Positive PCR test for COVID-19. Symptoms: sore throat. Date below reflects date of first symptoms. Date of PCR test was 08Jan2022. Test results received 09Jan2022. Follow-Up (11Jan2022): Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220101; Test Name; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20220105; Test Name: rapid test; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20220107; Test Name: Other rapid test; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20220108; Test Name: PCR; Test Result: Positive ; Comments: Nasal Swab; Test Date: 20220108; Test Name: Quick View rapid test; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20220109; Test Name: Quick View rapid test; Test Result: Positive ; Comments: Nasal Swab
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: known allergies: No other medical history: No
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 22.01.2022
- Impfdatum
- 02.01.2022
- Beginn
- 02.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Body temperature
Chills
Dysphonia
Headache
Immunisation
Oropharyngeal pain
Pain
Pyrexia
Symptomtext
Woke up running low grade fever; achy; chills; joint aches; headache; sore throat; hoarseness; booster dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 02Jan2022 11:45 (Lot number: FD0810) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Psoriatic arthritis" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Chronic bronchitis" (unspecified if ongoing); "known allergies: Yes" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0153, Location of injection: Leg Right, Vaccine Administration Time: 11:15), administration date: 09Apr2021, when the patient was 50 years old, for covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP7534, Location of injection: Arm Right, Vaccine Administration Time: 11:45), administration date: 19Mar2021, when the patient was 50 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 02Jan2022 11:45, outcome "unknown", described as "booster dose"; PYREXIA (non-serious) with onset 03Jan2022, outcome "not recovered", described as "Woke up running low grade fever"; PAIN (non-serious) with onset 03Jan2022, outcome "not recovered", described as "achy"; CHILLS (non-serious) with onset 03Jan2022, outcome "not recovered", described as "chills"; ARTHRALGIA (non-serious) with onset 03Jan2022, outcome "not recovered", described as "joint aches"; HEADACHE (non-serious) with onset 03Jan2022, outcome "not recovered", described as "headache"; OROPHARYNGEAL PAIN (non-serious) with onset 03Jan2022, outcome "not recovered", described as "sore throat"; DYSPHONIA (non-serious) with onset 03Jan2022, outcome "not recovered", described as "hoarseness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, pain, chills, arthralgia, headache, oropharyngeal pain, dysphonia. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220103; Test Name: Fever; Result Unstructured Data: Test Result:low grade
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Asthma; Chronic bronchitis; Hypothyroidism; Psoriatic arthritis.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 14.01.2022
- Impfdatum
- 03.11.2021
- Beginn
- 04.01.2022
- Tage bis Beginn
- 62,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Chills
Cough
Headache
Pyrexia
SARS-CoV-2 test positive
Symptomtext
cough fever chills and headache
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- + COVID test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 18.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 10,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Confusional state
Fatigue
Feeling abnormal
Tinnitus
Vertigo
Symptomtext
- Tinnitus onset approximately 1 week (between 7 and 10 days) after first Pfizer vaccine. - "Brain Fog" onset approximately 1 week (between 7 and 10 days) after first Pfizer vaccine. - Vertigo onset approximately 1 week (between 7 and 10 days) after first Pfizer vaccine. - Confusion onset approximately 1 week (between 7 and 10 days) after first Pfizer vaccine. - Chronic Fatigue onset approximately 1 week (between 7 and 10 days) after first Pfizer vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- - Doctor appointment (Nov 2nd) - Hearing Test (Nov 9th) - Doctor appointment (Nov 9th) - Ear, Nose, Throat specialist (Nov 18th) - MRI (Nov 28th) - Doctor appointment (Dec 3rd) - Doctor phone appointment (Dec 7th) - Doctor appointment (Dec 14th) - Ear, Nose, Throat specialist (Dec 22nd) - Vestibular testing (Dec 22nd) - Hearing test (Dec 22nd) - Doctor appointment (Dec 30th)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Sensitivity to Iodine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 09.01.2022
- Impfdatum
- 10.09.2021
- Beginn
- 17.09.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Dizziness
Nausea
Neuropathy peripheral
Vertigo
Symptomtext
Neuropathy in feet and thighs after 1 week following vaccination. Dizziness, nausea, vertigo, weakness after 2 months following vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 27.12.2021
- Impfdatum
- 14.04.2021
- Beginn
- 24.12.2021
- Tage bis Beginn
- 254,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Oropharyngeal pain
Pyrexia
Respiratory tract congestion
Symptomtext
cough, sore throat, congestion, fever 102.6, 100.5 at home last friday starting 12/24/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Dyslipidemia.
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 13.12.2021
- Impfdatum
- 13.02.2021
- Beginn
- 04.12.2021
- Tage bis Beginn
- 294,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dizziness
SARS-CoV-2 test positive
Urinary tract infection
Vulvovaginal pain
Symptomtext
12/04/2021 presented to ED for "vulvar pain, UTI and lightheadedness." PMHx of "partial hysterectomy and FIGO stage 1B squamous cell carcinoma of the vulva s/p radiation."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- 12/04/2021 SARS-CoV-2 (COVID-19) by NAA detected.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 07.12.2021
- Impfdatum
- 02.12.2021
- Beginn
- 03.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inflammation
Laboratory test
Pain in extremity
Ultrasound scan
Symptomtext
PATIENT EXPERIENCED INFLAMATION AND PAIN UNDER THE ARM ON INJECTION SITE ARM. PATIENT WAS SEEN BY DR OFFICE AND WAS GIVEN IBUPROFEN 800MG EVERY 8 HOURS AS NEEDED ON 12/06/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- LAB WORK AND PHYSICAL CHECK AND ULTRASOUND WAS DONE. WAITING ON RESULTS.
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- 03/12/2021 1ST DOSE , WAS TAKEN TO HOSPITAL FOR ALLERGIC REACTION.
- Staat
- NJ
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 04.12.2021
- Impfdatum
- 01.12.2021
- Beginn
- 01.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site swelling
Lymphadenopathy
Symptomtext
swelling of upper arm but not at the injection site. Just about an inch away. Swelling of lymph node in armpit of arm where injection was given. Nothing was done. Swelling subsided gradually over the next 48 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- none
- Andere Medikamente
- Effexor and OTC daily women's multi-vitamins
- Allergien
- no
- Vorherige Impfungen
- Had Lymph node swelling following this year's flu shot which was on 10/20/2021. That was the first time I'd experienced that si
- Staat
- GA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 29.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash erythematous
Symptomtext
Red rash all over the face. The face is sensitive to touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Pacemaker, gastric sleeve, Hashimoto's disease
- Andere Medikamente
- levocetirizine 5 MG tablet; L-LYSINE ORAL; multivitamin with folic acid tablet; ibuprofen 600 MG tablet;omeprazole 10 MG capsule; vitamin D3; bisoprolol fumarate 5 mg tablet; lisinopriL 2.5 MG tablet; triamcinolone 0.5 % ointment;Epi
- Allergien
- Iodine, seafood, bananas, metoprolol, environmental
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 28.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Body temperature
Erythema
Immunisation
Pyrexia
Unresponsive to stimuli
Symptomtext
Dose Number: 3; Verbally unresponsive; Temp of 101.9F; red face; Weakness; This is a spontaneous report received from contactable reporter (Pharmacist). A 78-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 28Oct2021 (Lot number: FD0810) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Multiple sclerosis" (unspecified if ongoing), notes: MS. Concomitant medications included: ACETAMINOPHEN; AMLODIPINE; AUGMENTIN [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM]; ACETYLSALICYLIC ACID; BENAZEPRIL; DALFAMPRIDINE; DICLOFENAC SODIUM; FLUTICASONE; MELATONIN; OXYBUTYNIN; SENNA [SENNA ALEXANDRINA]; GLYCOLAX; MVI [ASCORBIC ACID;DEXPANTHENOL;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE]; VITAMIN D [COLECALCIFEROL]; ATARAX [HYDROXYZINE HYDROCHLORIDE]; MILK OF MAGNESIA. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9269, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 08Feb2021, when the patient was 78 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EJ1686, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 18Jan2021, when the patient was 78 years old, for Covid-19 Immunization. The following information was reported: IMMUNISATION (hospitalization) with onset 28Oct2021, outcome "unknown", described as "Dose Number: 3"; UNRESPONSIVE TO STIMULI (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Verbally unresponsive"; PYREXIA (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Temp of 101.9F"; ERYTHEMA (hospitalization) with onset 28Oct2021, outcome "recovering", described as "red face"; ASTHENIA (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Weakness". The patient was hospitalized for immunisation, unresponsive to stimuli, pyrexia, erythema, asthenia (hospitalization duration: 7 day(s)). The patient underwent the following laboratory tests and procedures: body temperature: (28Oct2021) 101.9 Fahrenheit. It was unknown if therapeutic measures were taken as a result of unresponsive to stimuli, pyrexia, erythema, asthenia.; Sender's Comments: Based on available information and the close drug event temporal association, a possible contributory role of suspect product BNT162B2 to the development of event unresponsive to stimuli, pyrexia, erythema and asthenia cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 7,0
- Labordaten
- Test Date: 20211028; Test Name: Temp; Result Unstructured Data: Test Result:101.9 Fahrenheit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: MS
- Andere Medikamente
- ACETAMINOPHEN; AMLODIPINE; AUGMENTIN [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM]; ACETYLSALICYLIC ACID; BENAZEPRIL; DALFAMPRIDINE; DICLOFENAC SODIUM; FLUTICASONE; MELATONIN; OXYBUTYNIN; SENNA [SENNA ALEXANDRINA]; GLYCOLAX; MVI [ASCORBIC ACID
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 99,0
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 28.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Immunisation
Pallor
Peripheral coldness
Pyrexia
Unresponsive to stimuli
Symptomtext
Dose 3; Verbally unresponsive; Pale; Temp of 100.6; Cool to the touch; This is a spontaneous report received from contactable reporter (Pharmacist). A 99 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 28Oct2021 (Lot number: FD0810) at the age of 99 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "HTN" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "A.fib" (unspecified if ongoing); "CHF" (unspecified if ongoing); "Dysphagia" (unspecified if ongoing); "Asthenia" (unspecified if ongoing); "Post-stroke aphasia" (unspecified if ongoing); "HLP" (unspecified if ongoing); "hx TIA" (unspecified if ongoing); "COVID-19" (unspecified if ongoing); "CRF" (unspecified if ongoing). Concomitant medication(s) included: DIGOXIN; ELIQUIS; FUROSEMIDE; LOSARTAN; TYLENOL; METOPROLOL XL; Multivitamin. Past drug history included: Quinine, reaction(s): "Known allergies: Quinine". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9269, Location of injection: Left Arm , Route of Administration: Intramuscular), administration date: 11Feb2021, when the patient was 99 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3302, Location of injection: Right arm, Route of Administration: Intramuscular), administration date: 21Jan2021, when the patient was 99 years old, for COVID-19 Immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: IMMUNISATION (hospitalization) with onset 28Oct2021, outcome "unknown", described as "Dose 3"; UNRESPONSIVE TO STIMULI (hospitalization, medically significant) with onset 28Oct2021, outcome "recovering", described as "Verbally unresponsive"; PALLOR (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Pale"; PYREXIA (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Temp of 100.6"; PERIPHERAL COLDNESS (hospitalization) with onset 28Oct2021, outcome "recovering", described as "Cool to the touch". The patient was hospitalized for immunisation, unresponsive to stimuli, pallor, pyrexia, peripheral coldness (start date: 2021, discharge date: 2021, hospitalization duration: 7 day(s)). The patient underwent the following laboratory tests and procedures: body temperature: 100.6. Reported Event: On 28Oct2021, Resident was pale, cool to the touch, temp of 100.6 and verbally unresponsive. Did arouse with sternal rub. Was sent to hospital and remained there several days. Event resulted in hospitalization for 7 days. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, unknown if the patient has been tested for COVID-19.; Sender's Comments: As per available information, the causal association between the events IMMUNISATION, UNRESPONSIVE TO STIMULI, PALLOR, PYREXIA, PERIPHERAL COLDNESS and the suspect drug cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 7,0
- Labordaten
- Test Name: Temp; Result Unstructured Data: Test Result:100.6
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Aphasia; Asthenia; Atrial fibrillation; Chronic renal failure; Congestive heart failure; COVID-19; Dysphagia; Hyperkeratosis lenticularis perstans; Hypertension; Sulfonamide allergy; Transient ischemic attack
- Andere Medikamente
- DIGOXIN; ELIQUIS; FUROSEMIDE; LOSARTAN; TYLENOL; METOPROLOL XL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- 31.10.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature decreased
Chills
Feeling abnormal
Hyperpyrexia
Influenza like illness
Pain
Pain in extremity
Symptomtext
chills; felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side; she had almost 110 temperature; she wasn't feeling good; felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side; fluish; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 3 via an unspecified route of administration on 31Oct2021 10:00 (Batch/Lot Number: FD0810) as DOSE 3 (BOOSTER), 0.3 ML SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced she had almost 110 temperature, chills, felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side, she wasn't feeling good, felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side, fluish on 01Nov2021 with outcome of unknown. The patient underwent lab tests and procedures which included body temperature decreased:110 temperature on 01Nov2021. Therapeutic measures were taken as a result of she had almost 110 temperature, chills, felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side, felt very achy/when a new pain come out on her behind part but was not going down to her leg but to the back part where the hip is and the very next day it started also by the neck on the on the right side. No follow-up attempts are possible, no further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211101; Test Name: Temperature; Result Unstructured Data: Test Result:110 temperature
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 17.11.2021
- Impfdatum
- 03.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation
Pain
Pain in extremity
Total lung capacity
Vaccination site haemorrhage
Symptomtext
Received the booster dose of the Pfizer Covid vaccine on 03Nov2021; Soreness to her arm; States that blood ran out of her arm after the shot; She was sore; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 69-year-old female patient received bnt162b2 (COMIRNATY (mRNA), formulation: solution for injection, lot number: FD0810 and expiration date was not reported) via an unspecified route of administration, administered in right deltoid on 03Nov2021 at 15:30 (at the age of 69-years-old) as dose 3 (booster), single for covid-19 immunisation. Medical history included lung neoplasm malignant from Feb2020 to an unknown date Part of her lung was removed due to lung cancer for her to be protected against covid it was critical, non-tobacco user from an unknown date and unknown if ongoing Is not a smoker, patient had tired and achy for about 24 hours and then she was fine. Patient was not ill yesterday. Concomitant medications included influenza vaccine inact split 4v taken for an unspecified indication from 13Oct2021 to 13Oct2021. The patient previously received bnt162b2 (Dose 1, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot no: ER8737) on 03Apr2021 for COVID-19 immunization and on 24Apr2021, received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EW0175) for COVID-19 immunization. Age at vaccination was 68 years. Patient states her patient card has no expiry dates or NDC numbers written on it. On 03Nov2021 the patient experienced immunization. On an unspecified date in Nov2021the patient experienced slightly soreness to her arm and just feels concerned about this and is overwhelmed by her concern, states that blood ran out of her arm after the shot, she was sore patient never had anything like that before and just feels concerned about this and was overwhelmed by her concern. Patient explained that the shot was hurt a lot and then blood just spurted out of her arm. The patient was very very concerned this Pfizer Booster vaccine spurted out with the blood that was coming out of her arm and it did not take and she really didn't get any protection at all or that instead of being 90 percent protected she was 40 percent and she needs to know this. The patient underwent lab tests and procedures which included on an unspecified date total lung capacity with result 80 percentage. The outcome of events were unknown. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- Test Name: Lung capacity; Test Result: 80 %
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Ache; Lung cancer (Part of her lung was removed due to lung cancer.); Non-smoker (Is not a smoker); Tiredness
- Andere Medikamente
- QUADRIVALENT INFLUENZA VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Flushing
Immunisation
Pyrexia
Unresponsive to stimuli
Symptomtext
booster; high temperature; unresponsive to stimuli; flushing; This is a spontaneous report from contactable pharmacists. This pharmacist reported similar events for two patients. This is the second of 2 reports. A patient of unspecified age received third dose of bnt162b2 (COMIRNATY) via unspecified route of administration on unspecified date (lot number: FD0810, Expiration Date: 30Nov2021) as DOSE 3 (BOOSTER DOSE), SINGLE for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient previously received the first and second doses of COMIRNATY on unspecified dates for COVID-19 immunisation. On unspecified date, within 24 hours of receiving the booster, the patient experienced flushing, high temperature, and unresponsive to stimuli. The patient had been transported to the hospital and are still hospitalized. The pharmacist stated, it raised a red flag for them since they have given ten to thousand doses. Outcome of the events was unknown.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported events and suspect product BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : PFIZER INC-202101489288 same reporter/drug/AE, different patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Flushing
Immunisation
Pyrexia
Unresponsive to stimuli
Symptomtext
unresponsive to stimuli; flushing; high temperature; received third booster dose of Comirnaty; This is a spontaneous report from contactable pharmacists. This pharmacist reported similar events for two patients. This is the first of 2 reports. A patient of unspecified age received third dose of bnt162b2 (COMIRNATY) via unspecified route of administration on unspecified date (lot number: FD0810, Expiration Date: 30Nov2021) as DOSE 3 (BOOSTER DOSE), SINGLE for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient previously received the first and second doses of COMIRNATY on unspecified dates for COVID-19 immunisation. On unspecified date, within 24 hours of receiving the booster, the patient experienced flushing, high temperature, and unresponsive to stimuli. The patient had been transported to the hospital and are still hospitalized due to the events. The pharmacist stated, it raised a red flag for them since they have given ten to thousand doses. Outcome of the events was unknown.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events Unresponsive to stimuli, Flushing and Pyrexia and BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101489289 same reporter/drug/events, different patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 04.11.2021
- Impfdatum
- 22.10.2021
- Beginn
- 23.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash papular
Rash pruritic
Symptomtext
On 10/23 I noticed two bumps red raised bumps on my lower back. One 10/24 the rash has now spread from two bumps to now four and are now itchy. On 10/26 the rash has spread from the lower back up towards the middle of my back and middle of my chest and bilateral flanks. The rash became extremely itchy and more pronounced. I applied OTC hydrocortisone cream and took OTC Benadryl. The rash lasted for about a little over a week and started to subside however on 11/1/21 the rash returned and I then scheduled an appointment with my primary care physician .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- HSV-2
- Andere Medikamente
- N/A
- Allergien
- Iodine, latex, rubber, shellfish, chicken pox vaccine, coconut, seasonal allergies
- Vorherige Impfungen
- varicella
- Staat
- CT
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 01.11.2021
- Impfdatum
- 18.10.2021
- Beginn
- 18.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Malaise
Pyrexia
Symptomtext
Feverish, Intense chills throughout body, malaise.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- acid reflux
- Andere Medikamente
- -
- Allergien
- sulfa medications
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 01.11.2021
- Impfdatum
- 28.10.2021
- Beginn
- 30.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site rash
Injection site reaction
Rash
Rash erythematous
Rash papular
Rash pruritic
Skin warm
Symptomtext
Red, swollen, painful rash, warm to touch with minor itching . Size of affected area : 10cm X 8cm located 5 cm below injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Bronchiectasis, osteopenia, osteoarthritis
- Andere Medikamente
- Levothyroxine 75 mcg, daily
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 23.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Burning sensation
Disturbance in attention
Fatigue
Malaise
Mood altered
Pallor
Rash
Rash macular
Rash pruritic
Symptomtext
Have a rash on my collar bone up the back of my neck to the back of my head and a rash on my groin. The rash on my neck looked like red bloches had a burning feeling and itched bad and it itched worse when water hit it plus mad it feel like it was burning more. The rash on my groin has bright red blotches and bright pink blotches and itched badly and had a bad burning feeling plus it felt hot and was soar. Went to the my doctor on October 19, 2021 and got NYSTATIN 100000UCRE PER and CLOTRIM/BETA 1-0.05%CRE GLE. I use it 2 times a day for 2 weeks then take a week off and then 2 weeks on and rhen 1 week off and then I'm to call my doctor and let him know how the rash is and how I'm feeling. I also was not feeling well on Saturday October 30, 2021. I was pale, felt weak at times, could not focus at times, very tired off and on, felt like it was in a fog, moody, and at one point my face was grey. I went to bed at 9pm that night and slept till 8am on Sunday October 31, 2021. I do feel a little better but not quite 100% yet
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- No medical tests or labs on October 19, 2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Omeprazole 20mg once a day. Hydrocortisone 2.5% twice a day. Naproxen Sodium 220mg twice a day
- Allergien
- Hibiclens. Nasonex nasal spray
- Vorherige Impfungen
- Rash on my collar bone up my neck and on my groin. $9 years old. 10/23/2021 Pfizer FD0810
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 31.10.2021
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hallucination
Pain in extremity
Pyrexia
Symptomtext
Hallucinations, low grade fever, arm pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 28.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Unresponsive to stimuli
Symptomtext
Resident developed fever or 101.9 and unresponsive. Was sent to Hospital and admitted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- Unknown at this time
- Aktuelle Erkrankungen
- Urinary tract Infection 1 week prior
- Vorgeschichte
- Multiple sclerosis
- Andere Medikamente
- Augmentin Tablet 875-125 MG, hydrOXYzine HCl Tablet 25 MG, Ampyra Tablet Extended Release 12 Hour 10 MG (Dalfampridine ER), Tylenol Tablet 325 MG (Acetaminophen), Melatonin Tablet 3 MG, Oxybutynin Chloride ER Tablet Extended Release 24 Hou
- Allergien
- No Known allergys
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 26.10.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Symptomtext
Pain in shoulder area on same side as shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma, LBP
- Andere Medikamente
- Vitamin D3, lisinopril, cetirizine, esomeprazole, paroxetine
- Allergien
- nickel
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Symptomtext
itching of feet,palms of hands, and hairline at nape of neck
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic Lyme,Fibromyalgia, kidney stones,arthritis
- Andere Medikamente
- Xanax,Protonix
- Allergien
- Amoxicillin
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 26.10.2021
- Impfdatum
- 09.10.2021
- Beginn
- 10.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Gait disturbance
Muscle spasms
Myalgia
Pain in extremity
Walking aid user
Symptomtext
I was having severe sharp pains on my left side my hip and my entire leg; I still got this pain; I was having severe sharp pains on my left side my hip and my entire leg; I still got this pain; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: FD0810, Expiry Date, NDC number, UPC number: Unknown) via an unspecified route of administration, administered in Arm Left on 09Oct2021 at 11:50 (Age at Vaccination: 67 years-old) as DOSE 3, SINGLE for COVID-19 immunisation. When she was asked about NDC, UPC and Expiration date she stated it might be on the card, but she was not sure and the card was in her wallet and she cannot get to her wallet; asked to Hold on Please and then stated Okay so COVID vaccine 09Oct2021 and then FD0810. she did not see a booster number, but this said Pfizer for COVID-19 vaccination vial FD0810 (Further clarification unknown). Medical history included blood pressure from an unknown date and unknown if ongoing. Concomitant medication included was taking Blood Pressure Medicine (unspecified) from unknown date and for Blood Pressure. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via an unspecified route of administration on 09Mar2021 (Batch/Lot Number: EN62O3) (Age at Vaccination: 66 years-old) as DOSE 1, SINGLE and dose 2 via an unspecified route of administration on 01Apr2021 (Batch/Lot Number: ER2613) (Age at Vaccination: 66 years-old) as DOSE 2, SINGLE both taken for COVID-19 immunisation. When patient was probed for lot number for second dose, she stated she only had one dose. No, she had both Pfizer COVID-19 shot, was that what they were asking. Okay the first number EN62O3 (Confirmed for first dose) the second dose was Pfizer CR she means ER2613. Patient stated that she was calling because she received the Pfizer booster shot yesterday which was the 9th at her local pharmacy at public and she woke up this morning, was having severe sharp pains on her left side her hip and entire leg; still got this pain (10Oct2021, this morning). When probed for the confirmation of vaccine name as COVID-19 booster vaccine and date for booster shot as 09Oct2021, she stated Yes and Correct. She was informed about the role of Pfizer Drug Safety, she questioned, was she a doctor or nurse and answered no she was not. For mailing address, telephone patient stated No, she did not have the address at hand and nor have the telephone. When it was probed for if she was still experiencing issue, she stated Yes; All she know was the reaction started at this point and right now she was using a cane, a cart to help her get up and move around, that was all, she had not received any treatment she had put some pain cream (Treatment) on it to try to lessen the pain in my hip and my leg, it was like a Spasm. Lastly the patient stated that she just wanted to report it because she was going to call her (call primary care) physician's office tomorrow if she still got this pain or if still having the side effect in morning. The patient had an X-ray. Outcome of events was unknown. No Investigation Assessment was there. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 26.10.2021
- Impfdatum
- 09.10.2021
- Beginn
- 10.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Gait disturbance
Muscle spasms
Myalgia
Pain in extremity
Walking aid user
Symptomtext
I was having severe sharp pains on my left side my hip and my entire leg; I still got this pain; I was having severe sharp pains on my left side my hip and my entire leg; I still got this pain; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: FD0810, Expiry Date, NDC number, UPC number: Unknown) via an unspecified route of administration, administered in Arm Left on 09Oct2021 at 11:50 (Age at Vaccination: 67 years-old) as DOSE 3, SINGLE for COVID-19 immunisation. When she was asked about NDC, UPC and Expiration date she stated it might be on the card, but she was not sure and the card was in her wallet and she cannot get to her wallet; asked to Hold on Please and then stated Okay so COVID vaccine 09Oct2021 and then FD0810. she did not see a booster number, but this said Pfizer for COVID-19 vaccination vial FD0810 (Further clarification unknown). Medical history included blood pressure from an unknown date and unknown if ongoing. Concomitant medication included was taking Blood Pressure Medicine (unspecified) from unknown date and for Blood Pressure. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via an unspecified route of administration on 09Mar2021 (Batch/Lot Number: EN62O3) (Age at Vaccination: 66 years-old) as DOSE 1, SINGLE and dose 2 via an unspecified route of administration on 01Apr2021 (Batch/Lot Number: ER2613) (Age at Vaccination: 66 years-old) as DOSE 2, SINGLE both taken for COVID-19 immunisation. When patient was probed for lot number for second dose, she stated she only had one dose. No, she had both Pfizer COVID-19 shot, was that what they were asking. Okay the first number EN62O3 (Confirmed for first dose) the second dose was Pfizer CR she means ER2613. Patient stated that she was calling because she received the Pfizer booster shot yesterday which was the 9th at her local pharmacy at public and she woke up this morning, was having severe sharp pains on her left side her hip and entire leg; still got this pain (10Oct2021, this morning). When probed for the confirmation of vaccine name as COVID-19 booster vaccine and date for booster shot as 09Oct2021, she stated Yes and Correct. She was informed about the role of Pfizer Drug Safety, she questioned, was she a doctor or nurse and answered no she was not. For mailing address, telephone patient stated No, she did not have the address at hand and nor have the telephone. When it was probed for if she was still experiencing issue, she stated Yes; All she know was the reaction started at this point and right now she was using a cane, a cart to help her get up and move around, that was all, she had not received any treatment she had put some pain cream (Treatment) on it to try to lessen the pain in my hip and my leg, it was like a Spasm. Lastly the patient stated that she just wanted to report it because she was going to call her (call primary care) physician's office tomorrow if she still got this pain or if still having the side effect in morning. The patient had an X-ray. Outcome of events was unknown. No Investigation Assessment was there. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 25.10.2021
- Impfdatum
- 16.10.2021
- Beginn
- 17.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymph node pain
Lymphadenopathy
Symptomtext
COMIRNATY Pfizer-BioNTech COVID-19 Vaccine EUA - Left supraclavicular lymph node swelling, tenderness - starting morning after vaccine and continuing 10 days later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymph node pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- levothyroxine
- Allergien
- latex, penicillin
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 25.10.2021
- Impfdatum
- 13.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Illusion
Symptomtext
dizzy/light headed still-when i close my eyes it feels like i am falling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- one a day multi
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 23.10.2021
- Impfdatum
- 20.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysphonia
Fatigue
Feeling abnormal
Headache
Myalgia
Pain in extremity
Symptomtext
Sore arm Fatigue Hoarse voice Headache Muscle ache Cloudy head
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Multivitamin
- Allergien
- Penicillin and neomycin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 18.10.2021
- Beginn
- 18.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Urticaria
Symptomtext
pt reported severe hives and itching
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- nka
- Vorgeschichte
- nka
- Andere Medikamente
- nka
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 20.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- ID / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest discomfort
Impaired work ability
Pain
Symptomtext
My whole body ached and it gave me chest pressure that lasted 4 days and missed 1 day of work because of it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Diabetic, Heart , obesity
- Vorgeschichte
- Diabetic, Heart, Obesity
- Andere Medikamente
- Turmick, Vitamin C
- Allergien
- Biaxin, sulfa, oxyconton, IVP dye,
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 17.10.2021
- Tage bis Beginn
- 9,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Hypoaesthesia
Photophobia
Sinus disorder
Symptomtext
Facial numbness, eye and sinus sensitivity, headache
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- multivitamin
- Allergien
- Peanuts
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 17.08.2021
- Beginn
- 06.09.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Fatigue
Inflammation
Musculoskeletal stiffness
Neck pain
Pain
Pain in extremity
Rotator cuff syndrome
Tendon disorder
Symptomtext
The effects lasted 48 hrs. Sore arm, tiredness, stiffness. But about a month later both shoulders became inflamed and I started experiencing shooting pains particularly in the left arm, but also in the left hip, left knee, both sides of the neck, and right arm. The pains in the left arm are at times consistent with brakes that can last 30 seconds to a few minutes. More pains on the left side of the body than the right. The tendons in both shoulders are tight due to inflammation. More so on the left shoulder. The effect is Shoulder impingement syndrome.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- chiropractor and physiotherapist.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- milk thistle, vitamin D3
- Allergien
- Food sensitivity to all dairy, gluten, almonds etc.
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 15.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Chills
Dizziness
Hyperhidrosis
Symptomtext
Patient sat for 15 mins. While her and her mom were checking out at the register, she got really dizzy. We brought her a chair and she sat down and had cold chills and began sweating. After another 10-15 mins she began to feel a little better but still felt weak.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 15.10.2021
- Impfdatum
- 13.10.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Diarrhoea
Dizziness
Flushing
Headache
Pain
Pyrexia
Symptomtext
fever of 100, horrible body aches, headache, dizziness, diarrhea, chills, flushing
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- High Blood Pressure, Reiters syndrome, Crohns Disease
- Andere Medikamente
- Sulfasalazine, Omeprazole, Minocycline, Effexor, Losartan, Metoprolol/HCTZ, Synthroid
- Allergien
- Morphine
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 09.10.2021
- Impfdatum
- 07.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Chills
Lethargy
Symptomtext
Extreme chills, lethargic, joint pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Atorvastatin , Chlorthalidone , Amlodipine Besylate , Benazepril Hcl, Latanoprost, Prilosec, Aspirin
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 14.09.2021
- Impfdatum
- 24.08.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Flushing
Vertigo
Symptomtext
Dizziness Vertigo Feeling Flush
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Candesartan
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 25.05.2023
- Impfdatum
- 29.12.2021
- Beginn
- 14.10.2022
- Tage bis Beginn
- 289,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Transient ischaemic attack
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Transient ischaemic attack
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 28.12.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 11,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypoxia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoxia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 14.04.2023
- Impfdatum
- 03.01.2022
- Beginn
- 13.04.2023
- Tage bis Beginn
- 465,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Symptomtext
patient hospitalized
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 03.01.2023
- Impfdatum
- 27.09.2022
- Beginn
- 02.01.2023
- Tage bis Beginn
- 97,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Symptomtext
Patient vaccinated against then tested positive for COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 10.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 07.03.2022
- Beginn
- 07.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 21.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 06.02.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 31.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCNE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 15.03.2022
- Beginn
- 15.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. PATIENT HAD NO ADVERSE REACTIONS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STOAGE OF ACCINE. PATIENT HAD NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINE. THERE WERE NO ADVERSE REACTIONS ROM THE PATIENT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. THERE WAS NO ADVERSE REACTIONS TO PATIENT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
IMPROPER STORAGE OF VACCINES. THERE WERE NO ADVERSE REACTIONS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 23.08.2022
- Impfdatum
- 15.10.2021
- Beginn
- 01.08.2022
- Tage bis Beginn
- 290,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Vaccination failure
Symptomtext
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient. A 59-year-old female patient received BNT162b2 (BNT162B2), on 20Mar2021 as dose 1, single (Lot number: ER8727), in arm, on 10Apr2021 as dose 2, single (Lot number: EW0162), in arm and on 15Oct2021 as dose 3 (booster), 0.3 ml single (Lot number: FD0810) at the age of 58 years, in arm for COVID-19 immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of covid-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Sleep apnea
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 14.06.2022
- Impfdatum
- 19.04.2021
- Beginn
- 06.06.2022
- Tage bis Beginn
- 413,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Caesarean section
Induced labour
Maternal exposure before pregnancy
SARS-CoV-2 test positive
Symptomtext
6/6 27y.o. G1P0 at 38w3d by L=8.4wk US. Estimated Date of Delivery: 6/16/22 Presents to hospital for schedule IOL - CHTN. Dx 13 wks C-section birth, baby boy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 6/5 SARS-Cov-2 by NAA, Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 14.06.2022
- Impfdatum
- 14.04.2021
- Beginn
- 12.06.2022
- Tage bis Beginn
- 424,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Maternal exposure before pregnancy
Respiratory tract congestion
Rhonchi
Uterine contractions during pregnancy
Symptomtext
Pt was diagnosed with COVID at Urgent Care the day prior to admission to Labor and Delivery. She is 39 weeks and 6/7 days with active contractions. She complains of congestion, non-productive cough, and very mild rhonchi in the upper lobes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 22.12.2020
- Beginn
- 31.05.2022
- Tage bis Beginn
- 525,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Symptomtext
COVID hospitalization
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by state for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State of Colorado for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.10.1990
- Beginn
- 29.10.2021
- Tage bis Beginn
- 11.351,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.10.1990
- Beginn
- 29.10.2021
- Tage bis Beginn
- 11.351,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.10.1990
- Beginn
- 29.10.2021
- Tage bis Beginn
- 11.351,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- U
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 96,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 52,0
- Geschlecht
- U
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 98,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 76,0
- Geschlecht
- U
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State of for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State or COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 91,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved do for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 97,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 28.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State of for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 30.12.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 30.12.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 30.12.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -